ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[USP36, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, CIB1, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, UPF1, AQR, FBXO18, DTX3L, NCOA6, NSMCE2, RAD23A, DDB1, NEIL3, RAD51C, MSH3, TIMELESS, COPS7A, RAD51AP1, TFPT, POLR2B, RAD21, POLR2G, USP51, FANCI, POLQ, UBE2B, EYA2, XRCC5, INTS3, NONO, GINS4, APEX2, CDC7, GTF2H4, SETX, CDK9, SMUG1, HIST3H2A, COPS5, RAD51, UBE2T, POLE2]
GO:2000483;negative regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;7.8311634786251565;0.02523477878196853;0.8157270763441555;[PTPN22]
GO:0006284;base-excision repair;8.0;0.9326813400603323;0.8413406700301662;9.584072489921288;183.0506323445446;5.69953618377475;0.006126539929698291;0.6664745454937787;[POLB, SMUG1, USP36, POLQ, NEIL3, APEX2]
GO:1901222;regulation of NIK/NF-kappaB signaling;7.0;0.8436909121759173;0.7727648213451592;9.34084218004034;45.070113835906206;5.223196736079928;0.001508456149618737;0.6180338892438164;[SPHK1, ZFP91, TNFRSF10A, PTPN22, RELA, NFKBIA, NLRP12, IL23A, PRDX1, BCL3, NLRP3, CCL19, LIMS1, HAVCR2]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[DDB1, AQR, COPS5, POLR2B, CCNH, EP300, POLR2G, COPS7A, GTF2H4]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[NLRP12, IL23A, SPHK1, ZFP91, TNFRSF10A, CCL19, RELA, LIMS1, HAVCR2]
GO:0006167;AMP biosynthetic process;11.0;0.8933024483968273;0.8790801765280758;9.592156608321247;6171.320190070297;7.8311634786251565;0.2065485329340668;0.8329150168128974;[PRPS2]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[PDGFRB, SMG1, CD80, IMPAD1, PIK3C3, VAV1, HBEGF]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, SPHK1, ITGB2, CIB1, NLRC4, NFKB1, RELA, MTDH, TRIM14, NLRP3, RIPK1, KRAS, TRIM32]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[C3, MAP3K3, RRAS, SP1, TBXA2R, SPHK1, ITGB2, CTSH, CIB1, EPHA1, THBS1, MTDH]
GO:0072583;clathrin-dependent endocytosis;7.0;0.8436909121759173;0.7727648213451592;9.223059144383958;30.046907922432062;6.558197802812269;0.0010056429677022863;0.6863059058804069;[GAK, AP2S1, CLTA, FNBP1L]
GO:0033539;fatty acid beta-oxidation using acyl-CoA dehydrogenase;10.0;1.0;0.9152410118609203;9.628524252492122;581.3170730496397;7.069023426578259;0.019456159283571563;0.7767511986393403;[ACOX2, ETFA, ETFB]
GO:0000184;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;10.0;0.8933024483968273;0.861892236059334;9.57851383191746;717.2549128915896;4.989581884898423;0.0240058764469685;0.6704084614939124;[UPF2, UPF1, RPS9, SMG1, RPL3, EIF4A3, RPL23A, CASC3, SMG5, PPP2CA, SKIV2L, ETF1, DCP1A, DCP2, RPL19]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[CDKN1C, USP36, CIITA, BTG2, NAB1, GFI1, GMNN, ARID4A, OTUD7B, IKZF1, IKZF2, YY1, FLCN, NIPBL, C1QBP, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, LRRFIP1, HIF1AN, ZNF564, DACT1, TLE4, ZNF485, TSC22D4, KLF12, PEG3, ZNF282, ARID1A, RUNX2, SIRT2, EID1, ILF3, SFRP1, BRMS1, NCOR1, ZNF93, TFDP2, TBL1XR1, PSPC1, MTF2, HOXB4, TIMELESS, LCOR, PPID, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, SUPT6H, RELA, ARNTL, MTDH, BCLAF1, RXRA, BAG3, TPR, HIVEP1, HESX1, SUDS3, MTA2, E2F7, ZNF189, E2F8, IRX1, TFAP2A, DR1, CREBBP, UBE2I, XRCC5, NFYC, NONO, H3F3A, NFKB1, PER2, CENPF, GFI1B, HIST3H2A, CDK5, CNOT1, NFIB, NFIC, PKIA, SP3, BCL3, ZNF658, NFE2L3, TAF7, EZH2, LIMS1]
GO:0030705;cytoskeleton-dependent intracellular transport;5.0;0.5960880403619941;0.5882850320419173;7.885554947433499;33.20429938101479;4.695669262696007;0.0011113180183532213;0.5303777563261461;[IFT122, TRAK1, FNBP1L, DYNLL2, RAB21, FXR1, AP3M1, ARHGAP21, TUBA1C, TUBA1B, SPAST, RHOT1, RAB6A, TNPO1, SPG11, CLUAP1, PAFAH1B1]
GO:0048488;synaptic vesicle endocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.00680757199006;6.599019797332524;0.0018410283465216937;0.6605944919115335;[KIAA1109, SYNJ1, CDK5]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[NCF1, MAML1, CCNH, GFI1, CD80, ARID4A, RORA, IKZF1, IKZF2, ELK1, YY1, ZXDC, DPF2, TRIM24, EP300, SOX8, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, ILF3, SFRP1, KARS, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, RAD21, HLTF, DVL3, SCAP, NLRP3, RIPK1, TFAP2A, DR1, CREBBP, PBX3, EIF2AK3, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, NFE2L3, NFE2L1, CDKN1C, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, AATF, FLCN, NIPBL, LBH, NUP62, ZNF485, SEC13, TBP, KLF13, PEG3, DTX3L, NCOA6, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, CREB3, GAL, TFDP2, ELF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, TP53INP2, TP53INP1, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, NFYC, ATAD2, ARID3B, GRHL1, USF2, CD4, NFIB, TNIP2, NFIC, CAMK4, MARS, PSMC1, TAF7, CAMK1]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[ELL, UBE2B, RIC8A, FLCN, CCNB1, RXRA, ALS2, MAFF, CCM2, SOX8, EIF4E2, ATP7A, APBA3, SEC24C]
GO:0031914;negative regulation of synaptic plasticity;8.0;0.9326813400603323;0.8413406700301662;9.533214072687796;41.65758488823441;8.16763571524637;0.0013942418768168238;0.7926932703116032;[CDK5]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[C1QBP, PDCD1LG2, HAVCR2]
GO:0051402;neuron apoptotic process;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;23.44398779513952;6.113511981550823;7.846491732841165E-4;0.6028862989048107;[POLB, PIGT, CDK5, DIABLO, MAX, BID]
GO:0032687;negative regulation of interferon-alpha production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.82850979692678;7.9853141584524145;0.00283913388220078;0.7592887026755414;[HAVCR2]
GO:0051403;stress-activated MAPK cascade;10.0;0.811012628672052;0.8207473261969463;9.451593544333043;288.8226961090722;5.500407508664414;0.009666635715219814;0.696532107649126;[TNIP2, CCM2, NFKB1]
GO:0034184;positive regulation of maintenance of mitotic sister chromatid cohesion;11.0;0.8653626801206646;0.8651102923899945;9.538912093802434;1023.0912809008746;8.16763571524637;0.03424194444937782;0.8501222226412654;[NSMCE2]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[CDK5, FES]
GO:0034067;protein localization to Golgi apparatus;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;32.77360880529348;6.686031174322154;0.001096903192380182;0.665044257777226;[GAK, RAB6A]
GO:0006294;nucleotide-excision repair, preincision complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;65.90281547005735;6.409777797693995;0.002205707925099542;0.6787156999164222;[DDB1, CCNH, GTF2H4]
GO:0030819;positive regulation of cAMP biosynthetic process;11.0;0.8653626801206646;0.8651102923899945;9.57973408832269;5453.910874973866;6.599019797332524;0.18253748878425521;0.7699031316510512;[CALM3, CALM1, CALM2, TSHR]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[GLS, ALS2, SYPL1, CDK5, VDAC3, MBP, NPTX1, SNCB, APBA3, SPG11, KCNK3, NTSR1, PAFAH1B1]
GO:1905711;response to phosphatidylethanolamine;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;46.27441626201878;9.777073627680469;0.0015487630680189079;0.7902410118609202;[CRLS1]
GO:0043113;receptor clustering;6.0;0.7671156992804218;0.7066781622303554;8.992535485772125;42.889232177334534;5.9928839937622085;0.0014354640031724087;0.6295966787287501;[CDK5, ITGB2, IFT122]
GO:0042147;retrograde transport, endosome to Golgi;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;84.48667651462847;5.311165509025885;0.0028276930298722367;0.5947335637161829;[TMEM87A, GOSR1, STX5, VPS54, VPS26B, RAB6A, PLEKHJ1]
GO:0006612;protein targeting to membrane;10.0;0.811012628672052;0.8207473261969463;9.414950152194063;149.73401455281405;4.753193106834193;0.0050114627152184205;0.6583195283905053;[PEX16, TRAM1, RPS9, PEX19, RPL3, NCF1, SSR2, RAB3IP, ZDHHC23, SRP54, ZDHHC24, ZDHHC6, RPL23A, CHMP4B, RAB8B, RPL19]
GO:0005513;detection of calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;27.95353479882516;7.212124270218933;9.355796531686605E-4;0.6919486831672181;[CALM3, CALM1, CALM2]
GO:1990416;cellular response to brain-derived neurotrophic factor stimulus;7.0;1.0;0.8509193652572005;9.628524252492122;97.48528473772852;7.697632086000634;0.003262744749111492;0.7445766281117727;[EIF4A3]
GO:0000070;mitotic sister chromatid segregation;6.0;1.0;0.8231203125901445;9.628524252492122;56.84344269090966;6.311337724880743;0.0019024988710876387;0.6458824173477649;[ESPL1, ZNF207, CDCA8, NDC80, ZWINT, MAD2L1]
GO:0070830;bicellular tight junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;56.140948375987016;6.280566066213989;0.001878987018571015;0.6443087532925187;[PDCD6IP, RAB13, ECT2, MTDH]
GO:0018023;peptidyl-lysine trimethylation;10.0;0.8436909121759173;0.837086467948879;9.461470167828956;368.6575771449121;6.444869117505266;0.012338637336761129;0.7448319182472036;[SETD3, ARID4A]
GO:0018026;peptidyl-lysine monomethylation;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;368.6575771449121;7.474488534686424;0.012338637336761129;0.7974867031240476;[SETD3]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[UPF2, NFKBIA, PRPS2, CDKN1A, CAD, LCP1, RPL19, EZH2]
GO:0018027;peptidyl-lysine dimethylation;10.0;0.8259837884571596;0.8282329060895002;9.423729839846109;368.6575771449121;7.212124270218933;0.012338637336761129;0.7840693824379941;[SETD3]
GO:0034613;cellular protein localization;4.0;0.4527475610289664;0.4763737805144832;6.332687386487793;26.8334375525691;2.8773505203955967;8.980910063585456E-4;0.39714783942351395;[RAB3B, TRAM1, SYS1, RPL3, NCF1, ITGB2, SRP54, BUB1B, ZDHHC6, ABCA12, IPO4, NIPBL, IPO8, NUP62, TMEM107, LAMP2, TMED2, LONP2, TNPO1, TNPO2, RAB8B, GSTK1, GRIPAP1, RPS9, SEC13, FCER1G, SSR2, COG3, ARMCX3, GAK, ACOX2, AGPS, CHMP4B, PIK3C3, MAPRE1, VAMP5, SLC27A2, KPNB1, ACOT4, EXOC1, BECN1, SEH1L, ROCK2, ZDHHC23, HSD17B4, ZDHHC24, RGPD1, TM9SF4, FBLN5, AP3M1, UGT8, RAD21, LMNA, HEATR3, BID, RAB6A, RAE1, RPL19, PEX16, BBS2, TIMM8B, TMEM30A, PEX19, TOR1A, PMM1, XRCC5, RAB3IP, IFT122, NUP153, RPL23A, TIMM44, RAB11A, SPCS2, CDK5, GOLGB1, SLMAP, VPS41, TSPAN17, RAB13, RAB3GAP2, DCP1A, RAB3GAP1, EZH2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[PDGFRB, IGFBP5, C1QBP, CD80, CCL19, THBS1, VAV1, STK3, HBEGF, MTDH]
GO:0035264;multicellular organism growth;3.0;1.0;0.6981203125901445;9.628524252492122;22.582921643529833;5.382624473008031;7.558300640989654E-4;0.47338797845741154;[WDR48, NDUFS6, TBL1XR1, H3F3A, TMED2, CCM2]
GO:0070509;calcium ion import;9.0;0.8259837884571596;0.8092325194088689;9.36615998802463;37.619827487335996;6.088194173566533;0.0012591017703544919;0.7075911583464645;[CDK5]
GO:0090314;positive regulation of protein targeting to membrane;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;497.0805077511855;6.343086423195323;0.016636837251019197;0.7396267465268138;[CDK5, ITGB2, CIB1]
GO:1903421;regulation of synaptic vesicle recycling;6.0;0.7671156992804218;0.7066781622303554;9.176539128749065;29.360544556841745;6.943860283624253;9.826710035429039E-4;0.6782296504172152;[TOR1A, CDK5, SH3GL1]
GO:0090312;positive regulation of protein deacetylation;9.0;0.8436909121759173;0.8180860812682478;9.500690880982237;445.87784815594415;6.686031174322154;0.014923130313768376;0.7381645703673706;[NIPBL, BRMS1]
GO:0006021;inositol biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;310.2505467811778;8.390779266560578;0.010383806593401594;0.7800242071602487;[IMPAD1]
GO:0000715;nucleotide-excision repair, DNA damage recognition;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.24116723228514;6.641579411751319;7.10922751455178E-4;0.6298916918429109;[DDB1, COPS5, COPS7A]
GO:1900034;regulation of cellular response to heat;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;29.43425144606613;5.970411137910149;9.851379067933503E-4;0.6284474158353811;[CREBBP, DNAJC7, BAG3, EP300, IER5]
GO:0043928;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;11.0;0.9326813400603323;0.8987696223598284;9.60383163990175;718.8643508040237;6.280566066213989;0.024059742885497587;0.7536173930320365;[HBS1L, CNOT6, SKIV2L, CNOT8, LSM5, DCP1A, EXOSC3, DCP2]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, MAP3K3, UBE2I, SLC20A1, ZDHHC13, RELA, MTDH, AKAP13, CD4, TFG, TNIP2, UBD, NUP62, RIPK1, CCL19, ECT2, TRIM32, TMED4]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[CDKN1C, BTG2, CDKN1A, ZWILCH, CCNF, GMNN, BUB1B, GPR132, RPS6KA2, ZNF207, CASP2, EP300, FBXO5, TOPBP1, DACT1, TIPIN, PRKAB1, ERN1, ESPL1, TFDP2, CTDSP2, TIMELESS, PRR11, MAX, THBS1, PPM1G, CCNB1, RAD21, TPR, TP53INP1, TP53BP2, E2F7, E2F8, FANCI, CDKN2C, INTS3, MAD2L1BP, CNOT10, CDC7, ZWINT, CDK9, CNOT6, CENPF, STAG2, RAD51, FAP, CDK5, CNOT1, CNOT8, EIF4G2, EZH2, MAD2L1]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[CDKN1A, DIABLO, CIB1, KRCC1, BBC3, POLB, TFPT, SGPL1, ZMAT1, BAG3, MKNK2, DPF2, ARL6IP5, TP53BP2, CASP2, EP300, RIPK1, ZNF622, BID, EYA2, G0S2, TNFRSF10A, ERN1, BCL3, DDIT4]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[FXR1, UPF1, XRN1, YTHDF3, DCP1A, TNPO1, EXOSC3, YWHAZ, DCP2]
GO:0045667;regulation of osteoblast differentiation;5.0;0.8259837884571596;0.7032329060895001;9.405380701177911;40.22549681874724;5.067543426368135;0.001346311177926675;0.5493954183502558;[HEMGN, SFRP1, TWSG1, IL6, IGFBP5, RUNX2, PIAS2]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[SF3B5, SF3B2, WBP4, EIF4A3, DDX42, DDX41, CASC3, USP39, EFTUD2, PABPN1, PCF11, U2AF2, POLR2B, SNRPB2, POLR2G, SMNDC1, RBM5, AQR, PRPF38A, GPKOW, BUD31, CPSF3, NONO, CPSF2, TFIP11, LSM5, SRRM1, PSPC1, PRPF3, SNRPG, CD2BP2, SLU7]
GO:0048813;dendrite morphogenesis;8.0;0.8259837884571596;0.7879918942285797;9.485423408851448;64.60914726719044;6.063501560976162;0.0021624100145753813;0.6850877518099798;[CDK5, TRAK1, ZNF365]
GO:0072362;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;14.0;1.0;0.9759193652572005;9.628524252492122;2832.3692675710054;9.777073627680469;0.09479685041875367;0.9759193652572005;[NCOR1]
GO:0016191;synaptic vesicle uncoating;9.0;1.0;0.896240625180289;9.628524252492122;42.883923758655996;8.16763571524637;0.0014352863351765049;0.8139338954918922;[GAK, SYNJ1, SH3GL1]
GO:0031338;regulation of vesicle fusion;6.0;0.7248374789738407;0.6855390520770648;8.935377071932177;48.20117096329211;5.514393750639154;0.0016132498139038735;0.6051266654433651;[VPS18, TRIM9, RABGAP1, VPS41, VPS11, TBC1D8, RUNDC1, EVI5L, TBC1D22A, VPS16]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[FCER1G, ITGB3, ITGA2, ITGB2, NEDD9, CCM2, VAV1]
GO:0097068;response to thyroxine;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;148.64568421023415;8.16763571524637;0.004975037278085989;0.7408135829017477;[CRLS1]
GO:0071035;nuclear polyadenylation-dependent rRNA catabolic process;12.0;1.0;0.9481203125901445;9.628524252492122;3262.0620107015693;7.697632086000634;0.10917827983297142;0.8417775754447168;[EXOSC3]
GO:0002218;activation of innate immune response;8.0;0.622025257344104;0.686012628672052;8.529911963824013;265.7077617868092;4.551326953967268;0.008892999665543976;0.6077550720842344;[COLEC12, FGA, CREBBP, FCER1G, XRCC5, NONO, ITGB2, FGG, NLRC4, TMEM173, LILRA2, TANK, NFKB1, RELA, NFKBIA, ITCH, TNIP2, PSPC1, EP300, RIPK1, PIK3C3, KRAS, HAVCR2]
GO:0071034;CUT catabolic process;9.0;0.9326813400603323;0.8625812952104552;9.59573442966913;772.6175925627858;8.390779266560578;0.02585881551238653;0.8253454670833372;[EXOSC3]
GO:0016079;synaptic vesicle exocytosis;9.0;0.8436909121759173;0.8180860812682478;9.510741216835738;175.934860638427;5.885253329569843;0.0058883814544733026;0.6972127541467594;[TRIM9, CDK5, SYTL3]
GO:0072368;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;12.0;0.9326813400603323;0.9144609826203107;9.604993755081928;2123.1341023658892;9.083926447120524;0.07105938770954712;0.9126727335416687;[NCOR1]
GO:0071038;nuclear polyadenylation-dependent tRNA catabolic process;12.0;1.0;0.9481203125901445;9.628524252492122;3261.523014200833;7.8311634786251565;0.10916024010515714;0.8486063770733797;[EXOSC3]
GO:0048709;oligodendrocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;23.145667324477426;6.518977089658987;7.746646556020492E-4;0.623621803389518;[CDKN2C, CDK5, SOX8, TSPAN2, CSK]
GO:0006270;DNA replication initiation;7.0;0.7980440201809971;0.7499413753476991;9.405380701177911;149.0421272461911;6.343086423195323;0.0049883058697239;0.6753050999230941;[CCNE2, GINS4, MCM10, CDC7, TOPBP1, MCM2]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[TNIP2, PIK3C3, HAVCR2]
GO:0090201;negative regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.8116675549172;6.943860283624253;0.015824581010188264;0.7513499630073597;[PRELID1, LMNA]
GO:2000273;positive regulation of signaling receptor activity;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;204.98744489530804;6.311337724880743;0.006860745303922797;0.6736814700148209;[NCF1, CDK5, BUD31]
GO:0032781;positive regulation of ATPase activity;6.0;0.7508913569872202;0.6985659910837546;8.781226392104918;51.416896668601964;5.8067817141283475;0.0017208772592953517;0.6200793994936333;[DNAJC7, DYNLL2]
GO:1900165;negative regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.5369298683007;7.8311634786251565;0.020701874395595732;0.8157270763441555;[PTPN22]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[YY1, RAD51AP1, POLQ, NIPBL, FEN1, WDR48, RAD51C, RAD51, FBXO18, GINS4, NSMCE2, CDC7]
GO:0006398;mRNA 3'-end processing by stem-loop binding and cleavage;10.0;1.0;0.9152410118609203;9.628524252492122;473.82980460404525;8.16763571524637;0.015858657140958726;0.8329342821725234;[CPSF3, CPSF2]
GO:1903799;negative regulation of production of miRNAs involved in gene silencing by miRNA;10.0;0.8933024483968273;0.861892236059334;9.5758805190067;949.8698671053862;7.697632086000634;0.031791289624636974;0.8088982747154926;[NCOR1]
GO:0048701;embryonic cranial skeleton morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;46.18089108149027;6.280566066213989;0.0015456328643938164;0.6443087532925187;[TBX1, TFAP2A, EIF4A3, RUNX2]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[CDK5]
GO:0043254;regulation of protein complex assembly;5.0;0.5023590972498763;0.5414205604858584;6.876988939450173;27.318252308649967;3.6656062881777913;9.14317319939619E-4;0.4777002879064576;[HRK, MTPN, NCKAP1, WIPF2, ARPC1A, KIF14, IQGAP2, SENP6, TRIM9, ATXN2, BCLAF1, NCLN, VPS11, EP300, NCKAP1L, ARFIP1, BID, CLASP1, DACT1, VPS16, VASP, VPS18, ACTR2, DR1, H3F3A, TFIP11, SPTB, GTF2H4, EML2, SIRT2, SETX, DDB1, VIL1, CNOT6, PAN3, ARPC2, CNOT1, FES, PSMC1, VPS41, TAF7, VDAC2, LCP1, MAPRE1, ARHGEF5]
GO:0008333;endosome to lysosome transport;6.0;0.8436909121759173;0.7449657686781032;9.36615998802463;62.67584315854233;5.769740442447999;0.0020977040659196657;0.618185107137305;[VPS18, DTX3L, VPS33A, VPS41, CLEC16A, VPS11, TRAK1, LYST, VPS16]
GO:0000722;telomere maintenance via recombination;9.0;0.9326813400603323;0.8625812952104552;9.593432932680852;337.7230221555657;7.212124270218933;0.011303285620559713;0.7650689957573628;[RAD51C, RAD51, NSMCE2]
GO:2000144;positive regulation of DNA-templated transcription, initiation;11.0;0.8933024483968273;0.8790801765280758;9.604426700913061;1600.8530134724567;6.444869117505266;0.05357910968674749;0.7620198587159455;[SETX, BCLAF1, PSMC1]
GO:0031325;positive regulation of cellular metabolic process;5.0;0.33430305599673393;0.45739253985928724;5.38799718009194;79.98476956498574;1.7414709347618875;0.0026770182557209064;0.37929991645132366;[TFRC, MAML1, CCNH, GFI1, EIF4A3, IKZF1, IKZF2, ELK1, UBE2L3, ZXDC, DPF2, TRIM24, ARL6IP5, SOX8, SKP2, IER5, IER2, FLT3LG, MED6, RUNX2, SFRP1, TWSG1, KARS, IL23A, RFX4, HOXB4, JTB, PSME2, EPHA1, CDCA2, EBI3, ZC3HAV1, MTDH, C3, FXR1, RAD21, HLTF, VPS11, SCAP, NCKAP1L, NTSR1, CREBBP, PRELID1, XRCC5, EDEM1, PBX3, EIF2AK3, PILRB, CDC7, ERLIN2, FLI1, SETX, STAG1, CALM3, CALM1, CALM2, EZH2, CDKN1C, BTG2, CDKN1A, WDR48, SETD3, ELL, ZFAND2A, KIF14, HOXC13, AATF, BBC3, AKAP13, NIPBL, C1QBP, CTSH, CCR2, HAVCR2, ZNF485, UPF1, SEC13, NCOA6, ELOVL5, SPHK1, ATPIF1, TMEM173, PPRC1, GFRA2, SIRT2, GAL, MTF2, TFEC, ARHGEF5, HBEGF, ZNF350, TANK, RELA, ARNTL, PPP2CA, SERTAD3, BCLAF1, RXRA, PPP1R7, GPBP1L1, CCL19, BID, EXOSC3, ZNF462, MAP3K3, YTHDF3, CCL20, NFYC, ATAD2, GPR55, GRHL1, CENPE, ITCH, NLRP12, NFIB, NFIC, CAMK4, MARS, PSMC1, RAB3GAP2, CAMK1, RAB3GAP1, NCF1, CD80, ARID4A, CIB1, RORA, COMT, YY1, EP300, ZNF564, PDGFRB, RPS9, FBXO18, PIAS2, ERN1, ARMCX3, ACLY, ILF3, BRMS1, TBL1XR1, TIMELESS, ADNP, DIABLO, MAX, CLEC16A, RLF, SUPT6H, STK3, RAP1B, CCNB1, DVL3, NLRP3, MBP, RIPK1, ECT2, MARK2, FANCI, TFAP2A, DR1, UBE2I, UBE2B, GLMN, TNFRSF10A, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CDK5, CNOT1, SP1, SP3, MAFF, BCL3, NFE2L3, CNOT8, NFE2L1, CIITA, ONECUT2, CALCOCO2, ITGB3, ITGB2, PTPN22, DDX41, FLCN, LBH, NUP62, DACT1, FGA, TBP, KLF13, KSR1, PEG3, DTX3L, ITGA2, FGG, PLAUR, ZFP91, ARNT, RAD23A, OXSR1, SENP2, SAFB, ARID1A, CREB3, ALS2, TFDP2, ELF4, LCP2, BECN1, VAC14, HDAC3, HDAC1, WBP2, ROCK2, NLRC4, LRP8, THBS1, U2AF2, TP53INP2, CCL5, TP53INP1, UBQLN1, POLR2G, CSK, ZNF622, MTA2, E2F7, E2F8, TBX1, RNF20, CHURC1, PDE6H, EYA2, ARID3B, HSPE1, USF2, TSHR, CD4, RAD51, TNIP2, TAF7, CDK2AP1, PTX3, KRAS, TRIM32, CD244]
GO:0010881;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;11.0;1.0;0.9324289523296623;9.628524252492122;219.4584201917244;6.8867018697843045;0.007345075824061613;0.7846152062148197;[CALM3, CALM1, CALM2]
GO:0035249;synaptic transmission, glutamatergic;8.0;1.0;0.875;9.628524252492122;25.73829654599903;6.444869117505266;8.61437622431563E-4;0.7045909063862833;[ALS2, CDK5]
GO:0010762;regulation of fibroblast migration;7.0;0.8259837884571596;0.7639112594857803;9.427853557029971;40.03709713961528;6.481236761676141;0.0013400056102148314;0.6823701146576509;[RFFL, MTA2, THBS1]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[FXR1, RPS9, IL6, RXRA, YTHDF3, ITGA2, C1QBP, CCL5, BCL3, EIF4A3, POLR2G, THBS1]
GO:0006085;acetyl-CoA biosynthetic process;7.0;0.811012628672052;0.7564256795932265;9.405380701177911;355.2115720243998;7.212124270218933;0.011888611645996552;0.7197477358342742;[ACLY]
GO:0002281;macrophage activation involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;81.79914540449643;7.379178354882098;0.0027377437822370863;0.7004918368257019;[SUCNR1, HAVCR2]
GO:0009116;nucleoside metabolic process;6.0;0.5127202928476964;0.5794804590139927;8.04289698875174;148.96441490805535;4.948759890378168;0.00498570490770306;0.5762001235249539;[PRPS2, UCK2, AHCYL1, APOBEC3F, APOBEC3H, IMPDH2, AMD1, CAD, PDE6B]
GO:0045842;positive regulation of mitotic metaphase/anaphase transition;11.0;0.9326813400603323;0.8987696223598284;9.60254876608886;1435.6381372244598;7.57984905034425;0.04804951646246229;0.8200627852632958;[ESPL1, NSMCE2, ANAPC5, ANAPC11]
GO:0006520;cellular amino acid metabolic process;6.0;0.406884124246779;0.526562374713534;6.526182243879872;77.81072980309767;4.002522082136061;0.0026042551013992716;0.5278094780068945;[BCKDHA, AHCYL1, TARSL2, BCKDHB, CAD, CPOX, CTNS, AARSD1, AGMAT, GLS, ALDH5A1, KARS, MTHFD1, PSAT1, RARS, MARS, MTHFD2L, NARS2, ATP7A, SERINC3, ALDH7A1]
GO:0045047;protein targeting to ER;10.0;0.8933024483968273;0.861892236059334;9.54514264355307;184.61581431307337;5.142344639450834;0.00617892516161263;0.6782207558659173;[RPS9, SPCS2, RPL3, PMM1, SRP54, CHMP4B, RPL23A, RPL19]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, ARF3, TRAM1, AHCYL1, RPL3, NCF1, SRP54, CLTA, ZDHHC6, IPO4, RAB43, IPO8, AP1G1, NUP62, LAMP2, TMED2, LONP2, TMED1, ARFIP1, EVI5L, TNPO1, TNPO2, TBC1D22A, RAB8B, TMED4, VPS18, GSTK1, GRIPAP1, TMED9, RPS9, SEC13, SSR2, COG3, TBC1D8, AP1B1, SYTL3, BCR, ACOX2, AGPS, CHMP4B, SLU7, SLC27A2, KPNB1, ACOT4, COPB2, COPA, RABGAP1, ZDHHC23, HSD17B4, ZDHHC24, DERL2, VPS26B, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, LMNA, VPS11, AP2S1, HEATR3, STX5, RAB28, BID, RAB6A, RAE1, RPL19, VPS16, PEX16, TIMM8B, PEX19, PMM1, RAB3IP, SYVN1, NUP153, RAB27B, RPL23A, TIMM44, RAB11A, ARCN1, NFKBIA, SPCS2, PAN3, CDK5, SNX17, VPS41, BCL3, RAB13, RAB18, RUNDC1, RAB3GAP2, SEC24C]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ERRFI1, RABGAP1, DOCK8, RIC8A, ABR, DOCK11, ARHGAP21, RGS1, CCL5, ARHGDIB, DVL3, NCKAP1L, EVI5L, CCL19, ECT2, A2M, TBC1D22A, STARD13, SEC13, CCL20, TBC1D8, ARHGAP25, VAV1, BCR, DEPDC1B, SFRP1, ALS2, GNAQ, RUNDC1, RAB3GAP2, PKP4, TAX1BP3, DOCK2, EPHA1, ARHGEF5, RAB3GAP1, EZH2, LIMS1]
GO:0030866;cortical actin cytoskeleton organization;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;53.946853691669205;6.088194173566533;0.0018055526440439148;0.63447084575632;[VIL1, NCKAP1, PDCD6IP, CDK5, EPB41, ROCK2, WIPF2, RAB13, NCKAP1L]
GO:0006637;acyl-CoA metabolic process;5.0;0.5902001590945054;0.5853410914081729;7.97986562690474;77.21017702370673;5.244474134527214;0.0025841551403354684;0.5584436629936305;[ACLY, ACOT7, ELOVL5, ACSL6, HSD17B4, SUCLG1, ELOVL6, DBI, ACOT4]
GO:0032801;receptor catabolic process;6.0;0.8436909121759173;0.7449657686781032;9.34084218004034;102.12013474586499;6.518977089658987;0.003417869007789623;0.6565011041187423;[BECN1, CDK5, SNX25, AP2S1, CLTA]
GO:0031954;positive regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;6.481236761676141;0.026061291479152104;0.7466917612613706;[CALM3, CALM1, CALM2]
GO:0006515;protein quality control for misfolded or incompletely synthesized proteins;7.0;0.8653626801206646;0.7836007053175329;9.36615998802463;51.84712944745551;6.518977089658987;0.001735276763219217;0.6843001567857983;[TOR1A, LONP2]
GO:0033211;adiponectin-activated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;55.92657384780918;8.16763571524637;0.0018718120960374526;0.7686126355688037;[ADIPOR2]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[PER2, GNL3L, DTX3L, CDK5, U2AF2, GLMN, FBXO5, SENP2, MAD2L1]
GO:0016575;histone deacetylation;9.0;0.7866048967936545;0.7895430735771163;9.396722638434797;357.60632662761185;5.682729065458369;0.011968761927426838;0.6868556538617572;[PER2, HDAC3, BRMS1, HDAC1, TBL1XR1, ARID4A, SUDS3, MTA2, SIRT2]
GO:0051966;regulation of synaptic transmission, glutamatergic;7.0;0.811012628672052;0.7564256795932265;9.405380701177911;30.61939422688933;5.528578385631111;0.001024803569108247;0.6336511210035629;[OXTR, CDK5, RAB3GAP1]
GO:0010452;histone H3-K36 methylation;11.0;0.8933024483968273;0.8790801765280758;9.56183287799345;767.5947827162904;7.8311634786251565;0.02569070658705971;0.8329150168128974;[SETD3]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[BCLAF1, FBXO18, SERINC3, BID]
GO:0034427;nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';11.0;0.9326813400603323;0.8987696223598284;9.60383163990175;718.8643508040237;7.474488534686424;0.024059742885497587;0.8146746435927894;[SKIV2L, EXOSC3]
GO:0046949;fatty-acyl-CoA biosynthetic process;7.0;0.7866048967936545;0.7442218136540277;9.352270875863963;404.0761203118406;6.409777797693995;0.01352406410193885;0.6787156999164222;[ACLY, ELOVL5, ACSL6, ELOVL6]
GO:2001140;positive regulation of phospholipid transport;8.0;0.8653626801206646;0.8076813400603323;9.456673995565463;204.69191378994475;7.697632086000634;0.006850854143787015;0.7686572628545723;[PRELID1]
GO:0090305;nucleic acid phosphodiester bond hydrolysis;6.0;0.6073376606709605;0.6267891429256247;8.355558576679234;112.24841944109592;4.100319825412187;0.0037568535816745637;0.5328108591460956;[FEN1, DCLRE1C, POP4, SMG5, PCF11, EXO1, EXOSC3, DFFA, CPSF6, REXO1, FBXO18, CPSF3, CPSF2, APEX2, RNASE3, GTF2H4, SND1, ERN1, DDB1, CNOT6, PAN3, XRN1, LAS1L, CNOT1, RPP21, CNOT8, DCP1A, DCP2, KPNB1]
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2922.0785093664276;6.193554689224359;0.09779933800857048;0.7648589874268262;[CCNB1, CCNH]
GO:0046826;negative regulation of protein export from nucleus;9.0;0.8436909121759173;0.8180860812682478;9.538912093802434;565.9502038013685;7.9853141584524145;0.018941843999116373;0.8046099625986299;[CDK5]
GO:1904263;positive regulation of TORC1 signaling;9.0;1.0;0.896240625180289;9.628524252492122;286.95354203151174;7.57984905034425;0.009604076810373322;0.7838744581139225;[SEC13, SEH1L, CLEC16A]
GO:0035751;regulation of lysosomal lumen pH;11.0;0.8933024483968273;0.8790801765280758;9.523163736834295;144.4590765595299;7.292166977892469;0.004834915287719184;0.8053507106995271;[VPS33A]
GO:2001022;positive regulation of response to DNA damage stimulus;7.0;0.7043150770688792;0.7030769037916401;8.890925309361343;86.91339641844894;5.382624473008031;0.0029089131611469855;0.6261870311244675;[BCLAF1, FBXO18, DTX3L, EYA2, TIMELESS]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[OXTR, AHCYL1, SUCNR1, ROCK2, DGKA, DEFB1, IQGAP2, CRHR1, RIC8A, HEBP1, C3, ABR, AKAP13, GPR132, GNG2, GNAT2, RGS1, TBXA2R, ADORA3, CCL5, NPPA, OR56B1, CCL19, ECT2, NTSR1, CCR2, PDGFRB, SPHK2, CCL20, SPHK1, GPR55, TSHR, VAV1, SFRP1, GAL, GNAQ, GNB2, NMUR1, CALM3, CALM1, DAGLB, CALM2, ARHGEF5]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[MTPN, PIGT, ROM1, RORA, RUNX2, PPP1CC, SFRP1, HERC1, CDK5, DDIT4, SOX8, ATP7A, IER2, PAFAH1B1]
GO:1901673;regulation of mitotic spindle assembly;10.0;1.0;0.9152410118609203;9.628524252492122;218.77880646863287;6.832634648514029;0.0073223297643623805;0.7646622655359331;[STAG1, STAG2, TPR, CHMP4B]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[CREBBP, POLR3C, XRCC5, EP300, PTPN22, DDX41, LRRFIP1, TMEM173, NFKB1, RELA]
GO:0032482;Rab protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;5.500407508664414;9.9090025448413E-4;0.6562910957882058;[RAB21, RAB3B, RAB43, RAB20, RAB13, RAB18, RAB27B, RAB28, RAB6A, RAB11A, RAB8B]
GO:0060316;positive regulation of ryanodine-sensitive calcium-release channel activity;14.0;1.0;0.9759193652572005;9.628524252492122;2786.515379930216;7.697632086000634;0.09326216206523613;0.8695766281117727;[CALM3, CALM1, CALM2]
GO:1902523;positive regulation of protein K63-linked ubiquitination;12.0;0.9326813400603323;0.9144609826203107;9.593432932680852;695.4271152056829;8.67846133901236;0.02327531970216374;0.8919372290569614;[PTPN22]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, CSTB, PDXK, SIGLEC9, CLEC12A, ITGB2, UBR4, IQGAP2, C3, RAP1B, HK3, PSMD7, PSMD2, PSMB1, LAMP2, CTSH, NCKAP1L, GUSB, RAB6A, SNAP29, ACTR2, SERPINB1, TMEM30A, FCER1G, XRCC5, HSPA6, PLAUR, COMMD3, RNASE3, TMEM173, LILRB3, UNC13D, NFKB1, SERPINB6, ACLY, IMPDH2, RAB18, PTX3, MNDA, DEGS1, DOCK2, ALDOA, SLC27A2, KPNB1]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[TFRC, CD80, EBI3, PDCD1LG2, CD4, IL6, HLA-DMB, IL23A, CCL5, HLA-DPB1, NCKAP1L, CCL19, CCR2, HLA-DPA1, HAVCR2]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[COLEC12, CD163L1, TFRC, WIPF2, ITGB3, ITGB2, STON1, CLTA, FNBP1L, RABEPK, LRP8, TM9SF4, KIAA1109, AP2S1, APOL1, SCARF1, FCER1G, AMBP, FNBP1, CDC7, UNC13D, MARCH3, RUFY1, GAK, SYNJ1, CDK5, SNX17, CD9, PIK3C3, DOCK2, CSNK1G1]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[ERRFI1, EIF2B4, BTG2, OXTR, ABCC2, IGFBP5, MAX, CAD, CRHR1, TSHR, NFKB1, RELA, RAP1B, GAL, SP1, MARS, NPPA, RAB13, SCAP, CSK, CYC1, RAB8B]
GO:0060315;negative regulation of ryanodine-sensitive calcium-release channel activity;11.0;1.0;0.9324289523296623;9.628524252492122;2557.621706734507;7.379178354882098;0.08560129681430756;0.8098004765652196;[CALM3, CALM1, CALM2]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[TRAPPC2, TRAPPC3, PPP6C, SEC13, TFG, TRAPPC6B, TMED2, STX5, KLHL12, SEC24C]
GO:0006896;Golgi to vacuole transport;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;63.41778050327052;7.069023426578259;0.0021225360411474587;0.7124295520356204;[GAK, AP1G1, VPS54]
GO:0006406;mRNA export from nucleus;9.0;0.8933024483968273;0.8428918493787028;9.523163736834295;121.36021434248079;5.132682728539097;0.004061817156940898;0.658726258611935;[UPF2, UPF1, SMG1, SEH1L, CPSF3, CPSF2, EIF4A3, NUP153, THOC2, CASC3, SMG5, SRRM1, ALKBH5, NXF3, PABPN1, U2AF2, TPR, NUP62, NUP43, SLU7, RAE1]
GO:0007616;long-term memory;7.0;1.0;0.8509193652572005;9.628524252492122;22.22653164046661;6.221725566191056;7.439020114266185E-4;0.6690987000520388;[CAMK4, CTNS]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN6, DCTN5, COPB2, COPA, DCTN4, GOSR1, DCTN3, KLHL12, RAB43, SPAST, TFG, TMED2, STX5, TMED1, TMED4, TRAPPC2, TRAPPC3, TMED9, COG4, COG3, COG1, DYNLL2, SPTB, ARCN1, TRAPPC6B, GOLGB1, SEC24C, SEC22C]
GO:0019395;fatty acid oxidation;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;147.7937623067202;5.446340287394138;0.004946524218655313;0.6535260955780609;[ACOX2, CPT2, HSD17B4, ETFA, ETFB, SLC27A2, ADIPOR2]
GO:0048213;Golgi vesicle prefusion complex stabilization;6.0;1.0;0.8231203125901445;9.628524252492122;44.51706700895919;9.083926447120524;0.0014899461700306506;0.7876727335416686;[COG4]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[CDKN1A, NCF1, CCNH, ITGB3, KIF14, CIB1, LRP8, THBS1, STK3, PPP2CA, AKAP13, CCNB1, CCL5, DVL3, NCKAP1L, RIPK1, CSK, CCL19, ECT2, MARK2, PDGFRB, MAP3K3, PDE6H, XRCC5, ZFP91, TNFRSF10A, PILRB, OXSR1, ERN1, CENPE, CD4, KARS, ALS2, CDK5, IL23A, JTB, LCP2, KRAS, CALM3, CAMK1, ADNP, CALM1, CALM2, ARHGEF5, EZH2]
GO:0046034;ATP metabolic process;10.0;0.6519675769143192;0.7412248003180799;9.106334870075816;1262.3387643731025;4.99795013456894;0.04224934241243719;0.6708364141712261;[TPI1, ADPGK, ATP5J, CTNS, ATP5I, BPGM, COX5B, ATP5O, ATP5F1, ATP5L, HK3, CYC1, ALDOA]
GO:0015914;phospholipid transport;7.0;0.7763722522362496;0.7391054913753253;9.040737587590003;67.00175910617337;5.618190544320798;0.0022424885796152832;0.638233890966345;[PRELID1, TMEM30A, PITPNB, STARD10, ABCA12]
GO:0070234;positive regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.47524002355703;7.138016298065211;0.00520361636495672;0.7802794972956796;[PRELID1, CCL5, PDCD1]
GO:1904380;endoplasmic reticulum mannose trimming;10.0;0.8436909121759173;0.837086467948879;9.446202695698167;249.61615283182627;7.004484905440688;0.008354427995328538;0.7734506956670166;[RNF103, EDEM1, SYVN1, DERL2, MAN1B1]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[BBS2, RAB3B, GRIPAP1, SYS1, FCER1G, ROCK2, ZDHHC23, ABCA12, RAB11A, GAK, SLMAP, RAB13, TMED2, VAMP5, RAB8B]
GO:0090307;mitotic spindle assembly;8.0;1.0;0.875;9.628524252492122;186.05212215721153;6.193554689224359;0.006226997092562797;0.6917386748366816;[TUBGCP2, ZNF207, KPNB1, CLASP1, RAB11A]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[PPP1R11, CCNF, UBE2Z, UBE2L3, TRIM9, NPEPPS, HERC4, HERC1, CDC26, TRIM24, TRIM69, SKP2, C18orf25, FBXO18, DTX3L, ZFP91, TRPC4AP, DDB1, KCTD10, MED20, ANAPC5, HIST1H2BC, HIST1H2BO, HIST1H2BJ, CDCA3, RNF38, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, VCPIP1, RNF213, UBD, HLTF, RFFL, RNF20, UBE2I, UBE2B, KLHL25, SYVN1, FBXL15, LNPEP, FBXL16, MARCH3, ITCH, SPSB1, RNF103, UBE2T, TSPAN17, KBTBD2, FBXL3, TRIM32, ASB3]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[WDR1, EPB41, WIPF2, LST1, ITGB2, CDC7, VRK2, VIL1, MKLN1, CFDP1, FES, ALDOA, CSNK1G1]
GO:0014003;oligodendrocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;6.558197802812269;0.001141266750656509;0.6256275524841266;[EIF2B4, CD9]
GO:0036151;phosphatidylcholine acyl-chain remodeling;8.0;1.0;0.875;9.628524252492122;185.56639978848355;6.481236761676141;0.0062107404020032226;0.7064507494004503;[PLA2G12A, DBI]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[RABGAP1, TBC1D8, RUNDC1, TAX1BP3, EVI5L, ECT2, EPHA1, TBC1D22A]
GO:0003351;epithelial cilium movement;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;21.364546253447678;6.641579411751319;7.15052136259578E-4;0.6298916918429109;[SPA17]
GO:0045861;negative regulation of proteolysis;8.0;0.612588685250814;0.681294342625407;8.712233520617966;337.1756827485802;3.92774884773361;0.011284966663181396;0.5758652587320976;[SERPINA3, CSTB, CSTA, ITIH2, DERL3, SERPINA10, CLEC16A, DERL2, NLRC4, UBE2Z, THBS1, GLG1, C3, NLRP7, LRIG2, RFFL, A2M, SERPINB1, CSNK2A1, AMBP, PLAUR, TNFRSF10A, SERPINB6, VIL1, CDK5]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[ITIH2, PRKCSH, SERPINA10, CCNF, NEDD8, COPS7A, MSLN, PSMB10, PSMA7, PSMD8, C3, TGOLN2, PSMD7, PSMB5, PSMD4, RBBP5, PSMD2, UBD, PSMB1, SKP2, APOL1, FGA, KLHL25, IGFBP5, FGG, FBXL15, FBXL16, RAB11A, DDB1, IL6, SPSB1, COPS5, PSMA1, PSMC1, RAB13, PSME2, FBXL3, ASB3]
GO:0006616;SRP-dependent cotranslational protein targeting to membrane, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;169.63248762716802;7.57984905034425;0.005677446701553932;0.8028748447945538;[SRP54]
GO:0001963;synaptic transmission, dopaminergic;8.0;1.0;0.875;9.628524252492122;25.73829654599903;7.069023426578259;8.61437622431563E-4;0.7365101867784198;[CDK5]
GO:0006614;SRP-dependent cotranslational protein targeting to membrane;12.0;1.0;0.9481203125901445;9.628524252492122;336.65241395888097;5.288437257948329;0.011267453327701498;0.718571239899105;[RPS9, RPL3, SRP54, RPL23A, RPL19]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, DCTN3, FBXL15, PKMYT1, CKAP5, CDC25A, CCNB1, PPME1, CEP70, SKP2, MAPRE1, CLASP1, PAFAH1B1]
GO:0006617;SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition;6.0;1.0;0.8231203125901445;9.628524252492122;44.51706700895919;8.67846133901236;0.0014899461700306506;0.7669372290569613;[SRP54]
GO:0072321;chaperone-mediated protein transport;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;57.348299591639034;7.474488534686424;0.0019193959772133386;0.7572456912631272;[TIMM8B, PEX19, TOR1A]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[TUBA1B, RPL3, IMPDH2, MCM2]
GO:0032465;regulation of cytokinesis;6.0;0.5930994877375815;0.6196700564589352;8.140447197062288;31.798591743249187;5.358233019883872;0.0010642702487719462;0.5971405984103235;[BECN1, AHCTF1, KIF14, RAB11A, FLCN, SPAST, NUP62, PKP4, PIK3C3, CALM3, KIF20A, CALM1, ECT2, CALM2, E2F7, E2F8]
GO:0016310;phosphorylation;5.0;0.5310727365277519;0.5557773801247963;6.876988939450173;24.405590426795786;2.7321685105510984;8.168331479794688E-4;0.42996423654933263;[OXTR, MAML1, CCNH, DGKA, CD80, IL5RA, BUB1B, STK19, RPS6KA2, CFL1, TRIM24, PDGFRB, CSNK2A1, VRK2, PRKAB1, ERN1, BCR, ILF3, KARS, EPHA1, CSNK1G1, ATP5J, ATP5I, ATP5O, PKMYT1, RASGRP4, ATP5L, STK3, NUAK1, CCNB1, STK35, STK38, STK38L, MBP, RIPK1, CYC1, MARK2, EIF2AK3, DOLK, CDC7, ERLIN2, CLK4, CLK3, NFKB1, SETX, CLK1, CDK9, GNPTG, UCK2, PAN3, CDK5, PTPRA, FES, CALM1, CIITA, SMG1, MAST3, ADPGK, HK3, AKAP13, ZMYM2, CTSH, TPI1, KSR1, SPHK2, SPHK1, CAD, BPGM, OXSR1, ATP5F1, GFRA2, SPTB, COASY, VAV1, GAK, PDIK1L, IMPAD1, FASTKD5, PIK3C3, ALDOA, HBEGF, PRPS2, PDXK, ROCK2, COX5B, PABPN1, CCL5, MKNK2, NCAM1, CSK, MAP3K3, GTF2H4, SNRK, TNIP2, CAMK4, CCM2, KRAS, CAMK1]
GO:0036148;phosphatidylglycerol acyl-chain remodeling;8.0;1.0;0.875;9.628524252492122;148.59002936247938;6.8867018697843045;0.004973174560417748;0.7271862538851576;[PLA2G12A, CRLS1]
GO:0016311;dephosphorylation;5.0;0.6835726970475526;0.6320273603846966;8.32924126836186;24.405590426795786;4.076630054289783;8.168331479794688E-4;0.4987200624199847;[EYA2, SSU72, DUSP28, PTPN22, SSH3, SGPP2, CDC25A, PPM1G, DUSP14, PPP1CB, PTP4A1, POLB, PPP2CA, PPP1CC, DUSP23, PPP6C, G6PC3, SYNJ1, PTPRA, CTDSP2, IMPAD1, ACP2]
GO:0033314;mitotic DNA replication checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;738.0966094602528;7.379178354882098;0.02470342927481251;0.8098004765652196;[TOPBP1]
GO:0045190;isotype switching;12.0;0.8259837884571596;0.8611122068187244;9.517298617381897;267.39842152832483;6.943860283624253;0.00894958452559752;0.8032296504172152;[EXO1, EXOSC3]
GO:1903076;regulation of protein localization to plasma membrane;7.0;0.7307253602413294;0.7162820453778652;9.117698628726131;62.75471671371763;5.346256828837156;0.0021003438928297916;0.6243271881103005;[VIL1, CDK5, PPFIA1, CIB1, CSK, RAB11A]
GO:2000191;regulation of fatty acid transport;7.0;0.7043150770688792;0.7030769037916401;8.935377071932177;63.493838046678675;6.641579411751319;0.0021250816186779843;0.6905700452391912;[NCOR1, THBS1, NTSR1]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[GAK, TOR1A, DNAJC7, HSPA6, HSPE1]
GO:1901215;negative regulation of neuron death;6.0;0.7586651285174919;0.7024528768488905;9.05316010758856;58.54459561550999;4.545965010825883;0.001959434928535777;0.5556011746527726;[BTG2, CDK5, PSMC1, NONO, KIF14, CHMP4B, KRAS, ADNP, SNCB, CPEB4]
GO:1903753;negative regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1764.046878661414;8.16763571524637;0.0590410614896785;0.8658135829017477;[PTPN22]
GO:0006633;fatty acid biosynthetic process;8.0;0.6493065804076676;0.6996532902038338;8.912904216080118;359.8485513982277;5.076593261888053;0.01204380717262807;0.6346172154986847;[ACLY, ACOT7, ELOVL5, DEGS1, ELOVL6, HSD17B8, PRKAB1, FADS1, MGLL]
GO:0006626;protein targeting to mitochondrion;10.0;1.0;0.9152410118609203;9.628524252492122;196.80778803422263;6.250713103064308;0.006586979549995513;0.734902770639515;[TIMM8B, TIMM44, BID]
GO:0002027;regulation of heart rate;7.0;0.7043150770688792;0.7030769037916401;8.712233520617966;26.867502833526505;5.233778845410465;8.992311406554274E-4;0.6185750588070984;[NPPA, CALM3, CALM1, CALM2]
GO:0006625;protein targeting to peroxisome;10.0;0.8933024483968273;0.861892236059334;9.56183287799345;237.37488197280172;5.572381008289503;0.007944723676105511;0.7002128357670632;[PEX16, GSTK1, PEX19, ACOX2, AGPS, HSD17B4, LONP2, SLC27A2, ACOT4, RAB8B]
GO:0097035;regulation of membrane lipid distribution;4.0;0.6913464685778243;0.5956732342889122;8.438940185618286;26.99109086293587;6.063501560976162;9.033675207777536E-4;0.5600877518099798;[PRELID1, TMEM30A]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[UPF1, ABCC2, CCL20, GFI1, CD80, PDCD1LG2, NFKB1, RELA, BCR, IL6, PABPN1, NLRP7, TBXA2R, TNIP2, NLRP3, HAVCR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[ANKRD17, COLEC12, HIST1H2BJ, NCF1, CFH, DEFB1, NLRC4, ZC3HAV1, LILRA2, LYST, RELA, C2, C3, PPP6C, PRDX1, C1QBP, SLAMF7, NLRP3, CSK, APOL1, HAVCR2, FGA, APOBEC3F, FCER1G, DTX3L, APOBEC3H, XRCC5, NONO, WRNIP1, RNASE3, TMEM173, SIRT2, NFKB1, ITCH, POLR3C, IL23A, FES, ELF4, PSPC1, POLR3E, TRIM14, PTX3, SERINC3, TRIM32, CD244, C1QC, HIST1H2BC]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[ITCH, TWSG1, CD80, GLMN, CTLA4, PDCD1LG2, HAVCR2]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[CEP70, RAB3IP, DCTN3, MAPRE1, CKAP5, CLASP1, RAB11A, PAFAH1B1]
GO:0006749;glutathione metabolic process;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;147.28945980206763;5.71663061713405;0.0049296456676673804;0.6154690682008903;[GSTK1, GSTA5, ALDH5A1, CTNS]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[CCNF, BUB1B, UBE2Z, UBE2L3, YY1, PSMD8, NPEPPS, PSMD7, PSMD4, PSMD2, CDC26, LONP2, SKP2, C18orf25, FBXO18, TRPC4AP, KCTD5, CDC25A, SFRP1, KCTD10, TBL1XR1, PSME2, CHMP4B, ANAPC5, UBR4, COPS7A, ANAPC11, C2, C3, VCPIP1, CCNB1, RHOT1, RNF213, UBD, NLRP3, USP51, RIPK1, AMZ2, UBE2I, TOR1A, UBE2B, KLHL25, EDEM1, LNPEP, ERLIN2, PGA3, PGA5, NFKB1, NFKBIA, NSFL1C, COPS5, RNF103, FBXL3, TPP1, USP36, WDR48, PPP1R11, USP32, KIF14, OTUD7B, USP39, SENP6, POLB, TRIM9, CASP2, CTSH, CTSE, USP46, FGA, SEC13, PDCD6IP, DTX3L, RHBDF2, FGG, RAD23A, SENP2, JOSD1, SIRT2, DDB1, PSMA1, ESPL1, PIK3C3, MAN1B1, USP41, BECN1, DERL3, RNF38, USP12, DERL2, NEDD8, LRP8, TANK, PARL, PSMB10, PSMA7, RELA, ARNTL, TFPT, PSMB5, TP53INP2, PSMB1, ADAM23, UBQLN1, RFFL, SEC11A, RNF20, LRRC29, SYVN1, FBXL15, FBXL16, CAPN13, KBTBD4, ITCH, SPSB1, SPCS2, XPNPEP1, FAP, TNIP2, PSMC1, TRIM32, C1QC, MAD2L1]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PDGFRB, FGA, CCL20, FGG, GPR55, CIB1, PTPN22, RAP1B, CD4, KARS, CCL5, CCL19, EPHA1, HAVCR2]
GO:0002826;negative regulation of T-helper 1 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.503361109538115;172.20109340032639;7.8311634786251565;0.005763415625186428;0.7754860644832351;[IL4R, HAVCR2]
GO:0031124;mRNA 3'-end processing;9.0;0.8436909121759173;0.8180860812682478;9.52844079393514;355.1646528804444;5.407625775213448;0.011887041304472852;0.6727868588050205;[AHCYL1, CPSF6, CPSF3, CPSF2, EIF4A3, SSU72, THOC2, CASC3, SRRM1, PABPN1, PCF11, U2AF2, SLU7]
GO:0050427;3'-phosphoadenosine 5'-phosphosulfate metabolic process;10.0;0.9326813400603323;0.8815816818910864;9.598671289342441;1067.6044110768958;6.599019797332524;0.035731758857152955;0.7527151911823093;[IMPAD1]
GO:0035725;sodium ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;113.92400819162063;5.014899692882714;0.0038129340292226534;0.6314622035107071;[SLC9A6, SLC20A1, PKD2L1]
GO:0071225;cellular response to muramyl dipeptide;7.0;1.0;0.8509193652572005;9.628524252492122;334.57737126116905;8.16763571524637;0.011198003516026267;0.7686126355688037;[PTPN22]
GO:0036258;multivesicular body assembly;7.0;1.0;0.8509193652572005;9.628524252492122;62.72328125453724;6.375876246018314;0.0020992917763011008;0.6769819729871445;[PDCD6IP, VTA1, CHMP4B, CHMP6, RAB11A]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[PDGFRB, MAP3K3, PDE6H, CCNH, CIB1, THBS1, STK3, ERN1, PPP2CA, AKAP13, CCNB1, KARS, ALS2, DVL3, RIPK1, CSK, KRAS, CALM3, CAMK1, CCL19, CALM1, CALM2, ARHGEF5, EZH2]
GO:0031126;snoRNA 3'-end processing;10.0;0.8259837884571596;0.8282329060895002;9.423729839846109;716.7806215657785;7.379178354882098;0.02399000234312808;0.7926125360964777;[CPSF3, EXOSC3]
GO:0007094;mitotic spindle assembly checkpoint;13.0;1.0;0.9625549647676366;9.628524252492122;1801.8011146821202;6.781341354126479;0.060304661792685066;0.8093530769822879;[CENPF, TPR, ZNF207, BUB1B, MAD2L1]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[FANCI, TOPBP1]
GO:1904570;negative regulation of selenocysteine incorporation;10.0;1.0;0.9152410118609203;9.628524252492122;1554.3692155490971;9.777073627680469;0.05202333880295477;0.9152410118609203;[EIF4A3]
GO:0031081;nuclear pore distribution;7.0;1.0;0.8509193652572005;9.628524252492122;71.75212521717813;8.67846133901236;0.0024014790582986725;0.7947362817240173;[SEC13]
GO:0034475;U4 snRNA 3'-end processing;11.0;1.0;0.9324289523296623;9.628524252492122;716.7806215657805;7.697632086000634;0.02399000234312815;0.8260862151842345;[EXOSC3]
GO:0016925;protein sumoylation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;311.84626772129184;6.250713103064308;0.010437213937211602;0.7159023839588838;[SENP6, UBE2I, SUMO3, NSMCE2, SENP2, PIAS2]
GO:0043508;negative regulation of JUN kinase activity;13.0;1.0;0.9625549647676366;9.628524252492122;4937.625749520049;7.138016298065211;0.16525789026176277;0.8275934502023958;[SFRP1, PTPN22]
GO:0034352;positive regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.22198505122242;9.777073627680469;0.003488216045967471;0.875;[CDK5]
GO:1904574;negative regulation of selenocysteine insertion sequence binding;7.0;1.0;0.8509193652572005;9.628524252492122;58.06757241112636;9.777073627680469;0.0019434693911780684;0.8509193652572005;[EIF4A3]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[RAB3B, AHCYL1, SYS1, RPL3, TFRC, NCF1, ZDHHC6, IPO4, RAB43, EIF4ENIF1, IPO8, LAMP2, LONP2, ARFIP1, TBC1D22A, VPS18, GSTK1, RPS9, VPS33A, COG4, VPS33B, COG3, AP1B1, COG1, SYTL3, BCR, RUFY1, UNC50, CHMP4B, KIF20A, SLC27A2, KPNB1, ACOT4, PPID, COPB2, COPA, SUCNR1, VPS26B, VPS8, VPS11, NLRP3, ECT2, RAB6A, ATP6V1F, VPS16, BBS2, TOR1A, PMM1, VTA1, RAB3IP, NUP153, RAB27B, TIMM44, NFKBIA, PAN3, CDK5, BCL3, ARF3, TRAM1, AHCTF1, SFT2D3, SRP54, CLTA, LYST, AP1G1, NUP62, TMED2, TMED1, EVI5L, TNPO1, TNPO2, SNAP29, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, PDCD6IP, DTX3L, SSR2, RHBDF2, FGG, TBC1D8, SENP2, AFTPH, GAL, ACOX2, AGPS, LCP2, CHMP6, SLU7, VAMP5, PAFAH1B1, EXOC1, SEC22C, RABGAP1, GOSR1, ZDHHC23, HSD17B4, ZDHHC24, DERL2, RRBP1, NLRC4, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, SNX25, LMNA, AP2S1, HEATR3, STX5, VPS54, CCL19, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, PEX19, SYVN1, RPL23A, RAB11A, ARCN1, CENPF, SPCS2, MCM3AP, SNX19, SNX17, SNX14, VPS41, RAB13, RAB18, RUNDC1, RAB3GAP2, APBA3, SEC24C]
GO:0000338;protein deneddylation;9.0;1.0;0.896240625180289;9.628524252492122;202.59641706362558;7.474488534686424;0.0067807197541817285;0.7784863164434164;[COPS5, TOR1A, COPS7A]
GO:0045006;DNA deamination;8.0;0.9326813400603323;0.8413406700301662;9.574457031221845;166.36310735944548;7.212124270218933;0.005568023486244473;0.7438283705770736;[APOBEC3F, APOBEC3H, EXOSC3]
GO:0043620;regulation of DNA-templated transcription in response to stress;10.0;0.6302958089695718;0.7303889163457062;8.89455507741192;277.5670074981562;5.407625775213448;0.009289917946874546;0.6917872454856517;[CREBBP, BCLAF1, BAG3, EP300, ARNT, HIF1AN, SIRT2, RELA]
GO:0021954;central nervous system neuron development;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;34.232648149996464;6.343086423195323;0.0011457359261972313;0.6146267465268138;[BTG2, CDK5, UQCRQ, GNAQ, ATP7A]
GO:1902715;positive regulation of interferon-gamma secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.8311634786251565;0.02521906460756386;0.8157270763441555;[PTPN22, CD244]
GO:0042776;mitochondrial ATP synthesis coupled proton transport;13.0;1.0;0.9625549647676366;9.628524252492122;10144.915177257948;6.943860283624253;0.3395411811519228;0.8176643025947071;[ATP5J, ATP5I, CYC1, COX5B, ATP5O, ATP5F1, ATP5L]
GO:0060766;negative regulation of androgen receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;234.23542340630428;7.292166977892469;0.007839648823214116;0.747921758369865;[SFRP1, HDAC1, PIAS2]
GO:0031998;regulation of fatty acid beta-oxidation;8.0;0.7763722522362496;0.7631861261181248;9.292052015870908;137.0296323771803;7.004484905440688;0.00458625847700161;0.7332096838060964;[LONP2]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[SEMA6B, PPP2CA, FLCN, SERTAD3, SFRP1, CDKN1A, GAL, CDKN2C, CDK5, NPPA, ADIPOR2]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[C12orf57, ALS2, CDK5, NFIB, NPTX1, PAFAH1B1]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[IL23A, BCL3, EBI3, HLA-DPB1, PTPN22, CD244, CCR2, HLA-DPA1, HAVCR2]
GO:0071656;negative regulation of granulocyte colony-stimulating factor production;7.0;1.0;0.8509193652572005;9.628524252492122;82.4613861827968;9.777073627680469;0.0027599083851087935;0.8509193652572005;[HAVCR2]
GO:0016255;attachment of GPI anchor to protein;7.0;1.0;0.8509193652572005;9.628524252492122;151.15475272427284;7.9853141584524145;0.005059013543235805;0.7592887026755414;[PIGS, PIGT]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[IL6, IL4R, MBP, TRIM32, HAVCR2]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[DCTN6, DCTN5, LAG3, SEC13, FCER1G, DCTN4, DCTN3, AP1B1, CLTA, KLC1, DYNLL2, KIF15, CENPE, HLA-DMA, HLA-DMB, AP1G1, HLA-DPB1, AP2S1, KIF2C, CTSE, HLA-DRB3, SEC24C, HLA-DQA1, HLA-DPA1]
GO:0032049;cardiolipin biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;810.2807285887932;7.8311634786251565;0.027119366780555196;0.7967266896635242;[CRLS1]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ERRFI1, BCL3, PTPN22, HAVCR2]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[IL6, SEH1L, HIST1H2BJ, PPP1R11, NLRP3, DEFB1, RNASE3, HIST1H2BC, HAVCR2]
GO:0035435;phosphate ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;110.11210983553856;7.138016298065211;0.003685353221730381;0.7400384854347593;[SLC25A3, SLC37A1, SLC20A1, SLC25A10]
GO:0010499;proteasomal ubiquitin-independent protein catabolic process;8.0;1.0;0.875;9.628524252492122;190.80819184730524;6.518977089658987;0.006386178464905405;0.7083807915285978;[PSMB5, PSMA1, KLHL25, PSMB1, PSMB10, PSMA7]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[RAB3B, NCKAP1, OXTR, DGKA, CD80, SIRPG, IL5RA, DEFB1, RAB43, DOCK11, RPS6KA2, ARHGDIB, CFL1, ARL6IP5, EP300, SNIP1, IFNAR2, PDGFRB, IGFBP5, ERN1, BCR, DEPDC1B, KARS, DDIT4, ELMO1, KPNB1, DIABLO, CLEC16A, ITPR2, KRCC1, CRHR1, RASGRP4, STK3, RAP1B, ABR, NUAK1, CCNB1, RHOT1, ZMAT1, RRAS, TBXA2R, STK38, TP53BP2, DVL3, STK38L, MBP, RIPK1, ECT2, RAB6A, MARK2, EIF2AK3, IFT122, CNOT10, RAB27B, NFKB1, SETX, NFKBIA, CNOT6, IRAK1BP1, COL1A2, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, NMUR1, CALM3, CNOT8, CALM1, CALM2, BTG2, CDKN1A, MCTP1, PRKCSH, MAST3, DOCK8, BBC3, POLB, FLCN, AKAP13, AKAP11, NKIRAS1, C1QBP, CASP2, CTSH, RAB8B, CCR2, KSR1, SPHK1, OXSR1, TMEM173, GFRA2, SPTB, SIRT2, VAV1, GAL, ALS2, TFDP2, TAX1BP3, PIK3C3, LCP2, LCP1, DOCK2, ARHGEF5, EXOC1, HBEGF, ROCK2, TANK, RELA, RAB21, PPP2CA, GNG2, RAB20, PABPN1, CCL5, TIFA, MKNK2, NCAM1, ZNF622, RAB28, BID, E2F7, E2F8, MAP3K3, CCL20, TSHR, RAB11A, SNRK, ITCH, TNIP2, CAMK4, RAB13, RAB18, CCM2, KRAS, CAMK1, ASB3]
GO:0090502;RNA phosphodiester bond hydrolysis, endonucleolytic;8.0;0.6799073451904818;0.7149536725952409;8.878218658092228;231.13671471601307;5.395046993006588;0.007735937832006836;0.6509029541176994;[ERN1, FEN1, LAS1L, EXO1, POP4, CPSF3, RPP21]
GO:1903377;negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;11.0;0.9326813400603323;0.8987696223598284;9.605534734267422;1836.779214688724;8.16763571524637;0.06147534732165983;0.8501222226412654;[NONO]
GO:0006695;cholesterol biosynthetic process;7.0;0.8653626801206646;0.7836007053175329;9.50592193039979;430.3580998185219;6.039404009397101;0.014403698303781551;0.6597747671587765;[ACLY]
GO:1904469;positive regulation of tumor necrosis factor secretion;10.0;1.0;0.9152410118609203;9.628524252492122;775.9675723657698;7.292166977892469;0.025970936321606315;0.7881627702307852;[HAVCR2]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[SPAG16, HDAC3, TUBGCP2, CIB1, TUBA1C, CCNB1, TUBA1B, SPAST, KIF19, NUF2, LMNA, ZNF207, FBXO5, CLASP1, MARK2, BBS2, UBE2B, CKAP5, IQCG, NDC80, RAB11A, NSFL1C, CENPE, NIN, SON, NCOR1, ESPL1, CDK5, FES, TBCE, KIF2C, KIF20A, VAMP4, CALM1, MAPRE1, KPNB1, PAFAH1B1]
GO:1900425;negative regulation of defense response to bacterium;7.0;0.7671156992804218;0.7344772148974115;9.265618758802754;222.83389978997275;7.9853141584524145;0.0074580500884805735;0.7592887026755414;[SIGLEC11, SIRT2, HAVCR2]
GO:0000467;exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);11.0;1.0;0.9324289523296623;9.628524252492122;1183.020562188518;7.8311634786251565;0.03959463356706662;0.8329150168128974;[EXOSC3]
GO:0001682;tRNA 5'-leader removal;11.0;1.0;0.9324289523296623;9.628524252492122;715.7997923127639;7.474488534686424;0.023957174870718703;0.8146746435927894;[POP4, RPP21]
GO:1904903;ESCRT III complex disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;38.04764185170599;7.474488534686424;0.0012734203321220245;0.7053660038532718;[VTA1]
GO:0009966;regulation of signal transduction;5.0;0.3290196849396939;0.45475085433076723;5.351858133476067;37.58855813399747;1.7469895334129066;0.0012580552132388425;0.37958213784297784;[ERRFI1, MAML1, GFI1, EIF4A3, TFG, TRIM24, ARL6IP5, SKP2, CSNK2A1, FLT3LG, RUNX2, BCR, DEPDC1B, SFRP1, TWSG1, KARS, IL23A, RFX4, DDIT4, VDAC2, EPHA1, SEH1L, EBI3, APCDD1, GLG1, IL22RA2, MTDH, C3, ABR, NUAK1, RHOT1, RNF213, RRAS, RDH11, PRDX1, TP53BP2, A2M, NTSR1, CREBBP, STARD13, PRELID1, STARD10, EIF2AK3, CALM3, CALM1, CALM2, EZH2, CDKN1C, HRK, KIF14, OTUD7B, BBC3, AKAP13, AKAP11, C1QBP, CTSH, HAVCR2, TMED4, SEC13, SPHK1, ATPIF1, ZDHHC13, GFRA2, VAV1, GAL, NCOR1, TAX1BP3, ARHGEF5, MGLL, PAFAH1B1, HBEGF, SLC20A1, LILRA2, TANK, RELA, ARNTL, PPP2CA, BCLAF1, SNX25, LMNA, CCL19, BID, MAP3K3, CCL20, GPR55, SYVN1, G0S2, ITCH, NLRP12, LIMS1, NCF1, CD80, CIB1, RORA, RGS1, NPPA, ARHGDIB, WWC3, EP300, FAM3C, SH3GL1, TLE4, IFNAR2, PDGFRB, FBXO18, IGFBP5, VRK2, PIAS2, ERN1, SLC9A6, TBL1XR1, PKP4, ANKRD17, COPA, CLEC16A, KLHL12, RASGRP4, STK3, RAP1B, ARHGAP21, UBD, STK38, DVL3, NLRP3, RIPK1, ECT2, UBE2I, UBE2B, AMBP, NONO, IFT122, TNFRSF10A, ARHGAP25, NFKB1, NFKBIA, IL6, COPS5, CDK5, CNOT1, GNAQ, RCAN3, BCL3, SERINC3, ONECUT2, ITGB3, PTPN22, DUSP14, FLCN, LBH, PSD4, NUP62, CASP2, HIF1AN, DACT1, FGA, TBP, KSR1, PVRIG, BUD31, RHBDF2, FGG, PLAUR, ZFP91, ARNT, SENP2, YWHAZ, CREB3, ALS2, TFDP2, CHMP6, BECN1, HDAC3, HIST1H2BJ, HDAC1, WBP2, NLRC4, THBS1, NCLN, CCL5, TP53INP1, UBQLN1, PDE6B, CSK, LRIG2, ZNF622, RFFL, TBX1, CMTM7, PDE6H, EYA2, FBXL15, CD4, PIK3IP1, TNIP2, TSPAN17, TAF7, KRAS, TRIM32, KCNK3]
GO:0042304;regulation of fatty acid biosynthetic process;7.0;0.6954798709641801;0.6986593007392905;9.0094850440859;138.57858976749046;6.113511981550823;0.004638100686884144;0.663564652301091;[ELOVL5, SCAP, ERLIN2, ADIPOR2]
GO:0002652;regulation of tolerance induction dependent upon immune response;7.0;0.6913464685778243;0.6965925995461126;9.117698628726131;69.78820826809242;8.67846133901236;0.002335748525423278;0.7947362817240173;[HAVCR2]
GO:1900426;positive regulation of defense response to bacterium;7.0;0.7671156992804218;0.7344772148974115;9.265618758802754;222.62122828472002;7.57984905034425;0.007450932164591693;0.738553198190834;[HAVCR2]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[NLRP12, NCKAP1L, CSK, PTPN22, HAVCR2]
GO:0007416;synapse assembly;4.0;0.8436909121759173;0.6718454560879586;9.117698628726131;35.85243951974866;5.500407508664414;0.0011999488856252476;0.5312910957882058;[CDK5]
GO:0016241;regulation of macroautophagy;7.0;0.6729672293956388;0.6874029799550199;8.606873004960141;45.30384692040349;4.7081694254602375;0.0015162789856107417;0.5916953686275062;[ERN1, BECN1, USP36, CDK5, CALCOCO2, CLEC16A, CHMP4B, RAB3GAP2, VPS26B, RAB3GAP1, EXOC1]
GO:2000521;negative regulation of immunological synapse formation;8.0;1.0;0.875;9.628524252492122;159.58048984171964;9.083926447120524;0.005341015381885652;0.839552420951524;[HAVCR2]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[FGA, SPCS2, RHBDF2, FGG, CASP2, CTSH, LONP2, PIK3C3, CTSE, SEC11A]
GO:0070433;negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;403.9920680879125;8.67846133901236;0.013521250949646067;0.8400575416471059;[PTPN22]
GO:0032712;negative regulation of interleukin-3 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;9.777073627680469;0.002174371849661483;0.8231203125901445;[HAVCR2]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[FANCI, DCTN3, KIF14, CDC7, CKAP5, RAB11A, CDC25A, CENPF, GPR132, CCNB1, RAD51C, PKIA, RAD21, CEP70, TOPBP1, MAPRE1, CLASP1, PAFAH1B1]
GO:0042438;melanin biosynthetic process;6.0;0.8933024483968273;0.7697715367885581;9.537552474286395;304.50060054653846;7.292166977892469;0.010191361067543862;0.6960420709600095;[CTNS]
GO:0014044;Schwann cell development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;8.390779266560578;0.001141266750656509;0.7193458537639684;[CDK5]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, NSMCE2, ARNTL]
GO:0002063;chondrocyte development;4.0;0.8933024483968273;0.6966512241984136;9.474373572664863;32.15320660831846;6.943860283624253;0.001076138889173156;0.6051093378270707;[IMPAD1, EIF2AK3, RUNX2]
GO:0090394;negative regulation of excitatory postsynaptic potential;8.0;0.8933024483968273;0.8216512241984136;9.551563211355994;398.5774323400213;7.57984905034425;0.013340027964019948;0.7626338329336335;[EIF4A3]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[NDUFA7, NDUFB7, NDUFB10, NCF1, TXNRD1, COX4I1, NDUFA10, ETFA, ETFB, COX5B, COX6A1, COX7A2L, ALDH5A1, NDUFS7, UQCRQ, NDUFS6, IDH3B, DEGS1, CYC1, BID]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[MAML1, CCNH, GFI1, ARID4A, RORA, IKZF1, IKZF2, ELK1, YY1, DPF2, EP300, SOX8, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, RAD21, HLTF, SCAP, NLRP3, RIPK1, TFAP2A, DR1, CREBBP, PBX3, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, NFE2L1, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, AATF, FLCN, NIPBL, ZNF485, KLF13, PEG3, NCOA6, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, CREB3, GAL, TFDP2, ELF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIB, TNIP2, NFIC, PSMC1, TAF7, CAMK1]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[TFAP2A, CDK5, CASP2]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[MTPN, BTG2, EIF4E3, EIF4A3, CASC3, THBS1, FXR1, EIF4ENIF1, ATXN2, RXRA, C1QBP, CCL5, TPR, MKNK2, POLR2G, UPF1, EIF5B, EIF2B4, RPS9, KLHL25, IGFBP5, YTHDF3, ITGA2, EIF2AK3, CNOT10, PER2, CNOT6, ILF3, IL6, XRN1, CNOT1, CAPRIN1, BCL3, ETF1, EIF4E2, CNOT8, EIF4G2, CPEB4]
GO:0007628;adult walking behavior;4.0;1.0;0.75;9.628524252492122;34.938319875750295;6.518977089658987;0.0011693541237948906;0.5833807915285978;[CTNS]
GO:0010918;positive regulation of mitochondrial membrane potential;5.0;1.0;0.7902410118609202;9.628524252492122;24.658349685322438;7.57984905034425;8.252927728937918E-4;0.6778748447945537;[CTNS, BID]
GO:0001885;endothelial cell development;5.0;0.8259837884571596;0.7032329060895001;9.176539128749065;34.35043118565193;6.444869117505266;0.0011496780184027697;0.6198319182472036;[RAP1B, CCM2]
GO:0010917;negative regulation of mitochondrial membrane potential;5.0;1.0;0.7902410118609202;9.628524252492122;24.658349685322438;7.697632086000634;8.252927728937918E-4;0.6838982747154925;[PRELID1, ARL6IP5]
GO:0032703;negative regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.7325511899570465;0.002184000309729388;0.6674232935401965;[LAG3, HAVCR2]
GO:0002859;negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;10.0;1.0;0.9152410118609203;9.628524252492122;1230.9351562269924;9.083926447120524;0.04119829190919933;0.8797934328124444;[HAVCR2]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[ARID1A, PIAS2]
GO:0050855;regulation of B cell receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.86251036091213;6.686031174322154;0.0023047662495439825;0.692843310444282;[PTPN22]
GO:2001189;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;9.0;1.0;0.896240625180289;9.628524252492122;430.8793777811617;8.67846133901236;0.014421145008071396;0.8400575416471059;[HAVCR2]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[EIF2B4, CD4, BTN2A1, HLA-DPB1, LCP2, CSK, PTPN22, HLA-DRB3, HLA-DQA1, NFKB1, RELA, HLA-DPA1]
GO:0016236;macroautophagy;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;39.83166466328102;5.244474134527214;0.0013331299701091492;0.5584436629936305;[BECN1, GABARAPL1, CALCOCO2, VTA1, UBQLN1, C6orf106, CHMP4B, PIK3C3, CHMP6, DYNLL2, PRKAB1]
GO:0051149;positive regulation of muscle cell differentiation;6.0;0.7090535922965819;0.6776471087384355;8.848365694942547;114.55096530066652;5.346256828837156;0.0038339177194376536;0.5965281354432446;[TBX1, IL4R, SETD3, MAML1, FLT3LG, CAMK1, TRIM32]
GO:0030886;negative regulation of myeloid dendritic cell activation;7.0;1.0;0.8509193652572005;9.628524252492122;126.51759902192377;8.67846133901236;0.0042344301808169855;0.7947362817240173;[HAVCR2]
GO:0051028;mRNA transport;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;42.48893056556077;4.77312732173501;0.0014220662684744023;0.6190979532066485;[AHCTF1, SMG1, SEH1L, EIF4A3, CASC3, SUPT6H, SMG5, ALKBH5, NXF3, PABPN1, U2AF2, TPR, NUP62, NUP43, RAE1, UPF2, UPF1, SEC13, CPSF3, CPSF2, NUP153, THOC2, SENP2, SRRM1, MCM3AP, SLU7]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[BECN1, USP36, WDR48, USP32, USP12, OTUD7B, NEDD8, USP39, PSMB10, PSMA7, YY1, PSMD8, POLB, VCPIP1, TFPT, RHOT1, PSMD7, PSMB5, PSMD4, PSMD2, PSMB1, NLRP3, USP51, RIPK1, SKP2, USP46, RAD23A, JOSD1, CDC25A, NFKBIA, COPS5, PSMA1, TNIP2, PSMC1, PSME2, USP41]
GO:0006310;DNA recombination;7.0;0.612588685250814;0.6572137078826075;8.529911963824013;149.0421272461911;4.488806596985934;0.0049883058697239;0.5804771433779154;[FEN1, WDR48, DCLRE1C, YY1, POLB, RAD51AP1, TFPT, NIPBL, EXO1, RAD21, EXOSC3, POLQ, FBXO18, NCOA6, XRCC5, NONO, GINS4, NSMCE2, APEX2, WRNIP1, CDC7, SETX, RAD51C, RAD51, MSH3]
GO:0045830;positive regulation of isotype switching;10.0;0.8259837884571596;0.8282329060895002;9.562926970006309;1202.2270179172035;6.686031174322154;0.04023745635561778;0.7571649570480019;[TFRC, EXOSC3]
GO:0090160;Golgi to lysosome transport;8.0;1.0;0.875;9.628524252492122;114.4124755644324;7.697632086000634;0.0038292825925985686;0.7686572628545723;[GAK, AP1G1]
GO:0045956;positive regulation of calcium ion-dependent exocytosis;10.0;0.7763722522362496;0.8034271379790452;9.31486669363708;302.859176005535;6.7325511899570465;0.010136424065342656;0.7595439928109722;[CDK5]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[EIF2B4]
GO:0097352;autophagosome maturation;5.0;1.0;0.7902410118609202;9.628524252492122;38.04764185170599;6.599019797332524;0.0012734203321220245;0.6277151911823093;[GABARAPL1, SNX14, VPS33A, LAMP2, UBQLN1, SNAP29, VPS16]
GO:0032815;negative regulation of natural killer cell activation;8.0;0.811012628672052;0.780506314336026;9.392135474427892;160.49678057359853;7.697632086000634;0.005371682808073518;0.7686572628545723;[HAVCR2]
GO:1901409;positive regulation of phosphorylation of RNA polymerase II C-terminal domain;12.0;0.9326813400603323;0.9144609826203107;9.604426700913061;1031.3139065140633;7.57984905034425;0.034517148328768635;0.835754145523778;[CCNH]
GO:0050860;negative regulation of T cell receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;309.61561130321576;6.8867018697843045;0.010362555874359037;0.7271862538851576;[PVRIG, PTPN22]
GO:0006306;DNA methylation;9.0;0.7436939687323844;0.7680876095464813;9.253830803050711;389.4685312710283;5.948432231191374;0.01303516124271949;0.7004437261138039;[MTA2, EZH2]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TLE4, BCLAF1, TFRC, PMM1, XRCC5, MTF2, ADAM23, BSPRY]
GO:0030517;negative regulation of axon extension;11.0;0.8933024483968273;0.8790801765280758;9.582004236857228;1259.6079252935983;6.039404009397101;0.042157943686041796;0.7412843542312382;[SEMA6B, CDK5]
GO:0048675;axon extension;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;51.99108915072818;6.221725566191056;0.0017400949649324319;0.6084203466557585;[SLC9A6, CDK5, SPG11]
GO:0010801;negative regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;780.3281191277907;7.069023426578259;0.026116879897493853;0.7767511986393403;[DDIT4, CALM3, CALM1, CALM2, SIRT2]
GO:0032817;regulation of natural killer cell proliferation;8.0;0.8259837884571596;0.7879918942285797;9.485423408851448;79.99831622737885;7.57984905034425;0.0026774716503199995;0.7626338329336335;[IL23A, FLT3LG, PTPN22]
GO:0015936;coenzyme A metabolic process;10.0;0.8933024483968273;0.861892236059334;9.566003895510788;1025.616512810441;7.004484905440688;0.034326461688829836;0.7734506956670166;[ACLY, ACOT7, COASY]
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;778.6672313762616;6.375876246018314;0.026061291479152104;0.7413036195908642;[SPHK1, CALM3, CALM1, CALM2]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[UPF1, ABCC2, CCL20, GFI1, CD80, TNFRSF10A, PTPN22, PDCD1LG2, COMT, NFKB1, RELA, BCR, ABR, IL6, PABPN1, NLRP7, TBXA2R, TNIP2, NLRP3, HAVCR2]
GO:0032012;regulation of ARF protein signal transduction;9.0;0.8933024483968273;0.8428918493787028;9.461470167828956;48.758993290020136;6.943860283624253;0.0016319196251719597;0.7513499630073597;[PSD4]
GO:0050868;negative regulation of T cell activation;8.0;0.6393367784920305;0.6946683892460153;8.866384200445225;233.2008977034727;5.132682728539097;0.007805024178953029;0.6374856334316459;[ITCH, TWSG1, LAG3, IL4R, CD80, GLMN, CTLA4, PTPN22, PDCD1LG2, HAVCR2]
GO:0015811;L-cystine transport;10.0;0.9326813400603323;0.8815816818910864;9.571365838652174;254.95955250308688;8.390779266560578;0.008533266773578137;0.8443458537639685;[CTNS]
GO:0035644;phosphoanandamide dephosphorylation;6.0;1.0;0.8231203125901445;9.628524252492122;26.015028339229886;9.777073627680469;8.706995865085551E-4;0.8231203125901445;[PTPN22]
GO:0016226;iron-sulfur cluster assembly;5.0;0.6696747006330769;0.6250783621774587;8.347590407030058;61.314195544967326;6.7325511899570465;0.0020521309456966027;0.6345439928109722;[ISCA2, NUBPL, FAM96B]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[PPP2CA, GNL3L, DTX3L, CDK5, EPB41, EP300, TMEM173, MAPRE1, DACT1, STK3]
GO:0006361;transcription initiation from RNA polymerase I promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;6.311337724880743;0.015969835568764485;0.7190027299379095;[TBP, CCNH, TAF1A, POLR1E, GTF2H4]
GO:0034154;toll-like receptor 7 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[HAVCR2]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[ONECUT2, ELL, CCNH, INTS10, ARID4A, HOXC13, ELK1, AFF4, TRIM24, ZNF768, EP300, IER2, GTF2I, TBP, KLF13, ARNT, CREB3, NCOR1, TFDP2, ELF4, RFX4, TFEC, MED20, LCOR, WBP2, MAX, RPAP1, SUPT6H, GTF2E2, RELA, ARNTL, POLR2B, RAD21, TAF1A, HLTF, HIVEP1, POLR2G, HIVEP2, TFAP2A, POLR2J3, NFYC, INTS3, PBX3, ARID3B, DEK, GRHL1, USF2, GTF2H4, FLI1, NFKB1, CDK9, GFI1B, STAG1, TFCP2, COPS5, SP1, NFIB, NFIC, MAFF, NFE2L3, INTS4, TAF7, NFE2L1]
GO:0006487;protein N-linked glycosylation;8.0;0.7980440201809971;0.7740220100904985;9.34084218004034;176.5615275388073;5.500407508664414;0.005909355431665436;0.6562910957882058;[PMM1, DERL3, SYVN1]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[PDGFRB, MAP3K3, SMG1, CAD, EIF2AK3, VRK2, CLK4, CLK3, CLK1, ERN1, BCR, CDK5, FES, CAMK4, MKNK2, TRIM24, RIPK1, CSK, EPHA1, MARK2]
GO:0006363;termination of RNA polymerase I transcription;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;6.343086423195323;0.015969835568764485;0.7206263598461826;[TBP, CCNH, TAF1A, POLR1E, GTF2H4]
GO:0008542;visual learning;8.0;1.0;0.875;9.628524252492122;51.65827414420079;5.970411137910149;0.00172895594617802;0.6803271032452366;[RIC8A, CDK5, CTNS, KRAS]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[RPS9, WDR37, LAS1L, POP4, EIF4A3, IMP4, EXOSC3, BYSL]
GO:0008306;associative learning;7.0;0.8436909121759173;0.7727648213451592;9.223059144383958;22.449675191779697;5.459585514144159;7.513704252729093E-4;0.6301228223472235;[RIC8A, ACTR2, BTG2, CDK5, EIF4A3, CTNS, KRAS]
GO:0006369;termination of RNA polymerase II transcription;9.0;0.8933024483968273;0.8428918493787028;9.5544162803384;477.15162764714074;6.139487467954083;0.015969835568764485;0.7102142998068259;[SETX, PABPN1, PCF11, CPSF3, CPSF2, SNRPG, SSU72]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CREBBP, CDKN1A, TBP, MAML1, CCNH, RORA, ZNF45, GTF2H4, MED6, RUNX2, GTF2E2, CDK9, RXRA, POLR2B, NPPA, MED20, TAF7, POLR2G, GTF2I]
GO:0006368;transcription elongation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;5.459585514144159;0.015969835568764485;0.675444082270312;[CDK9, ELL, POLR2B, CCNH, POLR2G, SUPT6H, GTF2H4, AFF4]
GO:0006913;nucleocytoplasmic transport;6.0;0.6324783794010864;0.6393595022906877;8.152617732682543;33.20429938101479;4.2397393606619325;0.0011113180183532213;0.539940780662439;[SMG1, AHCYL1, SEH1L, EIF4A3, CASC3, RGPD1, SMG5, IPO4, AKAP13, ALKBH5, IPO8, NXF3, PABPN1, U2AF2, TPR, NUP62, LMNA, HEATR3, NUP43, TNPO1, TNPO2, RAE1, UPF2, UPF1, CPSF3, CPSF2, NUP153, THOC2, SRRM1, CDK5, RAB18, SNRPG, CAMK1, SLU7, KPNB1]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[ERN1, EIF2B4, THBS1]
GO:0071051;polyadenylation-dependent snoRNA 3'-end processing;11.0;1.0;0.9324289523296623;9.628524252492122;718.3900594782145;7.8311634786251565;0.024043868781657235;0.8329150168128974;[EXOSC3]
GO:0035914;skeletal muscle cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.845247994956144;7.050676185779127E-4;0.5489262542938873;[BTG2, MAFF, MED20, SOX8]
GO:0010977;negative regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;494.1264199049594;4.793467005972133;0.016537966589312465;0.6413787507847162;[SEMA6B, GAK, CDK5, GFI1, RUFY3, CIB1, THOC2, LRIG2, PAFAH1B1, ZNF365]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[VPS18, BECN1, GABARAPL1, CALCOCO2, VTA1, CLEC16A, PTPN22, PGA3, FNBP1L, DYNLL2, PRKAB1, PGA5, SIRT2, VPS41, LAMP2, VPS11, UBQLN1, C6orf106, CHMP4B, PIK3C3, CHMP6, MARK2]
GO:0018230;peptidyl-L-cysteine S-palmitoylation;10.0;1.0;0.9152410118609203;9.628524252492122;467.1984371929297;6.686031174322154;0.015636711241551894;0.7571649570480019;[ZDHHC23, ZDHHC24, ZDHHC6]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[IL4R, KARS, TNIP2, ITGB2, THBS1, HAVCR2]
GO:0098655;cation transmembrane transport;6.0;0.518007056267642;0.5821238407239655;7.133254815668575;43.36096628843346;3.3345334612122706;0.0014512525193377528;0.4936485088682041;[KCNK6, SLC25A3, SLC20A1, COX4I1, ITPR2, ATP5J, ATP5I, PKD2L1, COX5B, ATP5O, COX6A1, CLCN3, ATP5L, RHD, CYC1, SLC25A20, CCL19, ATP7A, ATP6V1F, SLC30A7, SLC36A1, TIMM8B, KCND1, CACNA2D3, ZDHHC13, ATP5F1, TRPC4AP, COX7A2L, SLC9A6, NDUFS7, KCNK3]
GO:0030220;platelet formation;5.0;1.0;0.7902410118609202;9.628524252492122;33.79744107268718;6.832634648514029;0.0011311699369806302;0.639662265535933;[WDR1, VPS33A, EP300, CIB1]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[TLE4, CSNK2A1, UBE2B, KLHL12, SENP2, APCDD1, DDB1, SFRP1, GNG2, GNAT2, AP2S1, DVL3, SDC1, TAX1BP3, CALM1, MARK2, DACT1, CSNK1G1]
GO:0017148;negative regulation of translation;8.0;0.6493065804076676;0.6996532902038338;9.081980546124052;1114.6737408694362;4.99795013456894;0.03730712696566269;0.6305954023103058;[UPF1, BTG2, IGFBP5, YTHDF3, EIF4A3, EIF2AK3, CNOT10, FXR1, EIF4ENIF1, ILF3, XRN1, CNOT1, CAPRIN1, TPR, EIF4E2, CNOT8, CPEB4]
GO:0010730;negative regulation of hydrogen peroxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;816.0323757863621;8.67846133901236;0.027311869236111414;0.8188169164668168;[CTNS]
GO:0051568;histone H3-K4 methylation;11.0;0.8653626801206646;0.8651102923899945;9.53008417967887;767.5947827162904;6.250713103064308;0.02569070658705971;0.7520907111082569;[SETD3, RBBP5, ARID4A, RLF]
GO:0048280;vesicle fusion with Golgi apparatus;7.0;0.811012628672052;0.7564256795932265;9.193206181234276;65.8060249050737;7.379178354882098;0.0022024684319953925;0.728290889492758;[STX5, SEC22C]
GO:0061001;regulation of dendritic spine morphogenesis;11.0;0.8933024483968273;0.8790801765280758;9.548481544818586;263.40314350006116;6.166155715036245;0.00881586616550832;0.747766442352181;[ACTR2, CDK5, CAPRIN1, CFL1, LRP8, PAFAH1B1]
GO:0034141;positive regulation of toll-like receptor 3 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;505.2767808384828;7.8311634786251565;0.01691115913508416;0.7967266896635242;[PTPN22]
GO:0061003;positive regulation of dendritic spine morphogenesis;12.0;1.0;0.9481203125901445;9.628524252492122;1908.9696229991087;6.943860283624253;0.06389149532065895;0.8032296504172152;[ACTR2, CAPRIN1, LRP8, PAFAH1B1]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[PDE6D, TMED2, IQGAP2]
GO:0034145;positive regulation of toll-like receptor 4 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;505.2767808384828;7.474488534686424;0.01691115913508416;0.7784863164434164;[PTPN22]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[NFKBIA, ITCH, NLRP12, BRMS1, ADORA3, GFI1, NLRP3, HAVCR2]
GO:0006370;7-methylguanosine mRNA capping;10.0;1.0;0.9152410118609203;9.628524252492122;354.47150569988446;6.250713103064308;0.011863842292131473;0.734902770639515;[POLR2B, CCNH, POLR2G, GTF2H4]
GO:0006013;mannose metabolic process;6.0;0.8259837884571596;0.7361122068187242;9.223059144383958;34.676020684410545;7.474488534686424;0.0011605752059146955;0.7053660038532718;[PMM1, MAN2B2]
GO:0046785;microtubule polymerization;7.0;1.0;0.8509193652572005;9.628524252492122;97.26999823215544;7.292166977892469;0.0032555393035152377;0.7238411236270654;[ZNF207, FBXO5, CKAP5]
GO:0006378;mRNA polyadenylation;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;472.4435102429282;6.250713103064308;0.015812259116276064;0.734902770639515;[AHCYL1, CPSF6, PCF11, CPSF3, CPSF2, SSU72]
GO:0042501;serine phosphorylation of STAT protein;10.0;1.0;0.9152410118609203;9.628524252492122;340.34620271031037;8.390779266560578;0.011391081113017789;0.8443458537639685;[CDK5]
GO:0006015;5-phosphoribose 1-diphosphate biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;251.39073302494668;7.9853141584524145;0.008413821597373791;0.7592887026755414;[PRPSAP1, PRPS2]
GO:0045580;regulation of T cell differentiation;8.0;0.5976175254657065;0.6738087627328533;8.663443356448536;131.165971977755;4.909539177224887;0.004390007040384596;0.626074061840201;[PRELID1, IL4R, IL23A, CAMK4, CD80, NLRP3, CTLA4, NCKAP1L, CCL19]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[CD4, FCER1G, SP3, BCL3, RORA, PTPN22, ATP7A, RUNX2, VAV1]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[RPL3, NAB1, GFI1, GMNN, EIF4A3, ARID4A, CASC3, IKZF1, IKZF2, UBE2Z, YY1, EIF4ENIF1, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, DIP2A, ZNF564, TLE4, RPS9, IGFBP5, ZNF282, SND1, RUNX2, ERN1, OLFM1, EID1, ILF3, SFRP1, BRMS1, ZNF93, XRN1, TBL1XR1, PSPC1, HOXB4, TIMELESS, ADNP, PPID, MAX, FOXG1, SUPT6H, GLG1, MTDH, FXR1, CCNB1, NLRP7, BAG3, TPR, HIVEP1, HESX1, SUDS3, A2M, BBS2, TFAP2A, DR1, CREBBP, UBE2I, XRCC5, NONO, H3F3A, EIF2AK3, CNOT10, LSM5, NFKB1, CDK9, CNOT6, PAN3, CDK5, CNOT1, PKIA, CAPRIN1, SP3, BCL3, ZNF658, NFE2L3, SKIV2L, CNOT8, DCP1A, EZH2, CPEB4, CDKN1C, USP36, HBS1L, CIITA, BTG2, CDKN1A, SMG1, OTUD7B, PTPN22, SMG5, FLCN, NIPBL, C1QBP, LRRFIP1, HIF1AN, DACT1, HAVCR2, UPF2, ZNF485, UPF1, TSC22D4, KLF12, PEG3, ARID1A, SIRT2, NCOR1, TFDP2, PTRH2, MTF2, LCOR, ETF1, EIF4E2, DCP2, HDAC3, ZNF350, HDAC1, NLRC4, LRP8, THBS1, RELA, ARNTL, PPP2CA, BCLAF1, RXRA, U2AF2, TP53INP1, POLR2G, EXOSC3, MTA2, E2F7, ZNF189, RPL19, E2F8, IRX1, RNF20, YTHDF3, NFYC, RPL23A, PER2, CENPF, GFI1B, HIST3H2A, NFIB, NFIC, TAF7, LIMS1]
GO:0010508;positive regulation of autophagy;7.0;0.7192862368539868;0.710562483684194;9.040737587590003;216.89043707272492;5.132682728539097;0.007259127740103463;0.6134049986888465;[BECN1, FLCN, CALCOCO2, TP53INP2, ATPIF1, TP53INP1, CLEC16A, RAB3GAP2, RAB3GAP1, MTDH]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[CCNF, KIF14, BUB1B, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, SEC13, FBXO18, RAD23A, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, DERL3, RNF38, DERL2, PSMB10, PSMA7, ANAPC11, ARNTL, CCNB1, PSMB5, PSMB1, UBQLN1, RFFL, UBE2I, LRRC29, UBE2B, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, PSMC1, FBXL3, MAD2L1]
GO:0032516;positive regulation of phosphoprotein phosphatase activity;10.0;0.8653626801206646;0.8479223519212526;9.5525383455142;1089.2705050571928;6.832634648514029;0.036456903524454846;0.7646622655359331;[PDGFRB, CALM3, CALM1, CALM2]
GO:0060837;blood vessel endothelial cell differentiation;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;25.300332287391186;8.16763571524637;8.467793528382013E-4;0.7408135829017477;[CCM2]
GO:0098789;pre-mRNA cleavage required for polyadenylation;10.0;1.0;0.9152410118609203;9.628524252492122;348.70325415094845;7.212124270218933;0.011670784103877944;0.7840693824379941;[CPSF6, CPSF3]
GO:0010507;negative regulation of autophagy;7.0;0.7436939687323844;0.7227663496233927;9.117698628726131;217.48068666745357;5.500407508664414;0.007278882862848883;0.6322104610454062;[BECN1, USP36, HERC1, CLEC16A, CHMP4B, PTPN22, SIRT2, RASIP1, EIF4G2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[NCF1, MAML1, CCNH, GFI1, CD80, EIF4A3, ARID4A, RORA, IKZF1, IKZF2, ELK1, YY1, ZXDC, DPF2, TRIM24, EP300, SOX8, IER5, ZNF564, IER2, RPS9, FLT3LG, PRKAB1, MED6, RUNX2, PIAS2, ERN1, ARMCX3, OLFM1, ILF3, SFRP1, KARS, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, C3, FXR1, CCNB1, RAD21, HLTF, DVL3, SCAP, NLRP3, RIPK1, TFAP2A, DR1, CREBBP, PBX3, EIF2AK3, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, NFE2L3, NFE2L1, CDKN1C, CIITA, SETD3, ONECUT2, ELL, PTPN22, DDX41, HOXC13, AATF, FLCN, NIPBL, LBH, C1QBP, NUP62, TMED2, CTSH, ZNF485, SEC13, TBP, KLF13, PEG3, DTX3L, NCOA6, ITGA2, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, CREB3, GAL, NCOR1, TFDP2, ELF4, MTF2, TFEC, POLR1E, HDAC3, ZNF350, HDAC1, WBP2, ROCK2, THBS1, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, U2AF2, TP53INP2, CCL5, TP53INP1, LMNA, TAF1A, POLR2G, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, YTHDF3, NFYC, ATAD2, ARID3B, DEK, GRHL1, USF2, CD4, NFIB, TNIP2, NFIC, CAMK4, MARS, PSMC1, TAF7, KRAS, CAMK1, RAB3GAP1, LIMS1]
GO:0010501;RNA secondary structure unwinding;7.0;1.0;0.8509193652572005;9.628524252492122;115.0816327851482;5.948432231191374;0.0038516786825735262;0.6551224661907153;[DDX59, EIF4A3, DDX42, DDX41]
GO:0034138;toll-like receptor 3 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.474488534686424;0.013811191226989502;0.8303660038532719;[COLEC12, TNIP2, RIPK1, HAVCR2]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[NFKBIA, CCL5, PTPN22, MTDH]
GO:0071049;nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription;6.0;1.0;0.8231203125901445;9.628524252492122;27.626668191684757;9.083926447120524;9.246397219885192E-4;0.7876727335416686;[EXOSC3]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[SMG1, MAST3, ROCK2, EIF2AK3, CDC7, VRK2, CLK1, ERN1, CCNB1, CDK5, CAMK4, STK38, MKNK2, STK38L, RIPK1, CAMK1, MARK2, CSNK1G1]
GO:0030334;regulation of cell migration;6.0;0.4770562410916853;0.5616484331359872;7.1128459440373675;36.74126027361157;3.1319826581748256;0.0012296969163702938;0.48329005138129355;[MCTP1, ONECUT2, DOCK8, ITGB3, KIF14, CIB1, FLCN, NIPBL, ADORA3, C1QBP, ARHGDIB, CTSH, ATP7A, CCR2, SEMA6B, PDGFRB, IGFBP5, ITGA2, SPHK1, PTP4A1, BCR, CREB3, SFRP1, KARS, IL23A, RUFY3, EPHA1, MAPRE1, HBEGF, CD151, ROCK2, THBS1, ABR, RRAS, TBXA2R, CCL5, TP53INP1, LMNA, NCKAP1L, LRIG2, CCL19, RFFL, MTA2, CLASP1, RNF20, MAP3K3, STARD13, CCL20, IDH2, RAB11A, VIL1, IL6, CDK5, SP1, TRIM32]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[CLK1, CSNK2A1, CDK5, ROCK2, CAD, CAMK1, OXSR1, MARK2]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[NLRP3, HAVCR2]
GO:0009298;GDP-mannose biosynthetic process;8.0;0.8933024483968273;0.8216512241984136;9.557065288509976;615.242755880766;8.390779266560578;0.02059162135679706;0.8041048419030481;[GMPPB, PMM1]
GO:0090114;COPII-coated vesicle budding;7.0;1.0;0.8509193652572005;9.628524252492122;41.05829977546847;7.9853141584524145;0.0013741843434141336;0.7592887026755414;[SEC13]
GO:0061154;endothelial tube morphogenesis;6.0;0.8259837884571596;0.7361122068187242;9.310070521373587;48.80114014223953;7.379178354882098;0.0016333302423860384;0.7004918368257019;[STARD13, CCM2]
GO:0006101;citrate metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;74.60362419578414;6.139487467954083;0.0024969161629301456;0.6648930398837374;[CS, ACLY, IDH2, IDH3B, SUCLG1, ACO2]
GO:0090110;cargo loading into COPII-coated vesicle;7.0;1.0;0.8509193652572005;9.628524252492122;99.46684456500904;7.212124270218933;0.0033290657732425078;0.7197477358342742;[SEC13, SEC24C]
GO:0006465;signal peptide processing;7.0;0.9326813400603323;0.8172600352873667;9.574457031221845;245.95175762031633;7.004484905440688;0.008231783985340883;0.7091290490632969;[SPCS2, SEC11A]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[SGPL1, GLMN, CCM2, RASIP1]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[OXTR, SMG1, MAST3, MAML1, CCNH, IL5RA, BUB1B, STK19, AKAP13, ZMYM2, RPS6KA2, CFL1, TRIM24, CTSH, PDGFRB, CSNK2A1, KSR1, CAD, VRK2, OXSR1, GFRA2, SPTB, PRKAB1, ERN1, BCR, GAK, ILF3, KARS, PDIK1L, FASTKD5, PIK3C3, EPHA1, HBEGF, CSNK1G1, ROCK2, PKMYT1, RASGRP4, STK3, NUAK1, CCNB1, PABPN1, STK35, CCL5, STK38, MKNK2, STK38L, NCAM1, MBP, RIPK1, CSK, MARK2, MAP3K3, EIF2AK3, CDC7, ERLIN2, CLK4, GTF2H4, CLK3, NFKB1, SETX, CLK1, CDK9, SNRK, PAN3, CDK5, PTPRA, FES, TNIP2, CAMK4, CCM2, KRAS, CAMK1, CALM1]
GO:1901844;regulation of cell communication by electrical coupling involved in cardiac conduction;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;47.34252427509125;7.57984905034425;0.0015845116819816402;0.7626338329336335;[CALM3, CALM1, CALM2]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[CIITA, BTG2, GFI1, OTUD7B, IKZF2, YY1, FLCN, NIPBL, C1QBP, SAP130, WWC3, EP300, SOX8, LRRFIP1, HIF1AN, ZNF564, DACT1, TLE4, KLF12, PEG3, ARID1A, SIRT2, EID1, BRMS1, NCOR1, TBL1XR1, MTF2, HOXB4, TIMELESS, LCOR, PPID, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, RELA, MTDH, RXRA, BAG3, TPR, HIVEP1, HESX1, SUDS3, MTA2, E2F7, ZNF189, E2F8, IRX1, TFAP2A, DR1, CREBBP, UBE2I, NFKB1, PER2, GFI1B, CNOT1, NFIB, NFIC, PKIA, SP3, NFE2L3, TAF7, EZH2]
GO:0051225;spindle assembly;7.0;0.7508913569872202;0.7263650437508107;9.168991923113682;86.84099814437;5.266214121163619;0.00290649005606778;0.6202338003175094;[HDAC3, NCOR1, TUBGCP2, ZNF207, FBXO5, MAPRE1, KPNB1, CLASP1, RAB11A]
GO:0051343;positive regulation of cyclic-nucleotide phosphodiesterase activity;6.0;1.0;0.8231203125901445;9.628524252492122;49.33745512692421;8.16763571524637;0.001651280222271285;0.7408135829017477;[CALM3, CALM1, CALM2]
GO:0034247;snoRNA splicing;10.0;1.0;0.9152410118609203;9.628524252492122;477.2673696298804;8.67846133901236;0.01597370934876576;0.8590579283277371;[CPSF3]
GO:2000210;positive regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.81651994310933;7.8311634786251565;0.0034746454936938316;0.7754860644832351;[BRMS1, PTRH2]
GO:0097428;protein maturation by iron-sulfur cluster transfer;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;50.16073049388722;7.57984905034425;0.0016788345079038099;0.710754145523778;[ISCA2]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTP4A1, DUSP23, PTPRA, EYA2, DUSP28, PTPN22, SSH3, CDC25A, DUSP14]
GO:0010950;positive regulation of endopeptidase activity;10.0;0.7436939687323844;0.7870879962271125;9.418803721510052;499.32903666023907;4.7018998124466425;0.01671209349006058;0.6556963869301439;[PRELID1, DIABLO, ROCK2, EIF2AK3, TNFRSF10A, NLRC4, HSPE1, BBC3, NLRP12, ARL6IP5, PSME2, NLRP3, CTSH, MBP, RIPK1, BID]
GO:0030204;chondroitin sulfate metabolic process;7.0;0.8436909121759173;0.7727648213451592;9.405380701177911;119.41350035796714;6.063501560976162;0.0039966623918080675;0.6610071170671804;[IMPAD1]
GO:0042407;cristae formation;7.0;1.0;0.8509193652572005;9.628524252492122;41.98985797947654;6.343086423195323;0.0014053627581543302;0.6753050999230941;[APOO, ATP5J, ATP5I, ATP5O, ATP5F1, ATP5L]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[CCNH, GFI1, IKZF1, IKZF2, ELK1, UBE2L3, SAP130, ZXDC, DPF2, TRIM24, SOX8, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SND1, EID1, EWSR1, RFX4, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, RPAP1, ZNF25, RAD21, HLTF, HIVEP1, HESX1, HIVEP2, ZNF264, ZNF260, XRCC5, INTS3, PBX3, FLI1, SOX30, STAG1, ZNF30, INTS4, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, INTS10, ATF7IP2, HOXC13, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, ZNF485, TSC22D4, COMMD3, BAZ1A, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR1, TFEC, MED20, VGLL4, ZNF350, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, GPBP1L1, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIB, NFIC, MARS, ZNF696, NAB1, ARID4A, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, TRAPPC2, TFAP2A, DR1, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, MAFF, BCL3, ZNF658, NFE2L3, CNOT8, TMEM18, ZNF532, ZNF410, NFE2L1, CIITA, ONECUT2, CHD1, AFF4, LBH, ZNF407, NUP62, ZNF768, ZNF525, LRRFIP1, HIF1AN, KLF12, TBP, KLF13, BUD31, ARNT, SAFB, ARID1A, CREB3, ZNF519, TFDP2, ELF4, LCOR, ZNF630, ITGB3BP, SMARCD2, HDAC3, HDAC1, WBP2, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, E2F7, ZNF189, E2F8, TBX1, POLR2J3, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3C, TNIP2, POLR3E, TAF7, MNDA]
GO:0060052;neurofilament cytoskeleton organization;6.0;1.0;0.8231203125901445;9.628524252492122;29.32696193356961;7.8311634786251565;9.815470233643841E-4;0.7236063770733796;[VPS54]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[MAML1, CCNH, GFI1, IKZF1, IKZF2, ELK1, UBE2L3, TIAL1, SAP130, ZXDC, DPF2, TRIM24, SOX8, FBXO5, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, FLT3LG, SND1, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, KARS, IL23A, EWSR1, RFX4, BOLA3, HOXB4, TRIM14, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, ZNF25, MTDH, RAD21, HLTF, HIVEP1, HESX1, SCAP, HIVEP2, ZNF264, CREBBP, ZNF260, XRCC5, H3F3A, PBX3, EIF2AK3, ERLIN2, FLI1, SOX30, SETX, STAG1, GOLGB1, PKIA, ZNF30, EZH2, CDKN1C, SETD5, AHCTF1, BTG2, CDKN1A, SETD3, ELL, ATF7IP2, OTUD7B, HOXC13, ZNF45, AATF, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, HAVCR2, ZNF485, TSC22D4, SEC13, NCOA6, SPHK1, COMMD3, BAZ1A, TMEM173, PPRC1, ZFX, MED29, SIRT2, VAV1, MED28, TOX4, GAL, NCOR1, MTF2, TFEC, MED20, VGLL4, ARHGEF5, ZNF350, NEDD8, TRAK1, ZNF69, RELA, ARNTL, PPP2CA, SERTAD3, BCLAF1, RXRA, UBN1, GPBP1L1, SCAND1, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ITCH, NLRP12, CENPF, GFI1B, HIST3H2A, NFIB, NFIC, CAMK4, MARS, PSMC1, CAMK1, ZNF696, LIMS1, NCF1, NAB1, CD80, GMNN, ARID4A, CIB1, RORA, YY1, ADORA3, WWC3, ZNF207, EP300, SNIP1, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, SSU72, PIAS2, ERN1, ARMCX3, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, GTF2E2, STK3, BAG3, TPR, ZNF549, ZNF548, DVL3, NLRP3, RIPK1, SUDS3, ZNF544, TRAPPC2, TFAP2A, DR1, UBE2I, NONO, CNOT10, NFKB1, CDK9, NFKBIA, CNOT6, IRAK1BP1, IL6, TFCP2, COPS5, CDK5, CNOT1, SP1, SP3, MAFF, BCL3, ZNF658, NFE2L3, CNOT8, ZNF532, ZNF410, NFE2L1, USP36, CIITA, ONECUT2, ITGB2, DDX41, CHD1, AFF4, FLCN, LBH, ZNF407, NUP62, GATAD1, ZNF768, ZNF525, LRRFIP1, HIF1AN, DACT1, KLF12, TBP, KLF13, PEG3, DTX3L, BUD31, ZFP91, ARNT, SENP2, SAFB, ARID1A, CREB3, ZNF519, TFDP2, SETBP1, ELF4, LCOR, ZNF630, ITGB3BP, MTPN, SMARCD2, HDAC3, HDAC1, WBP2, NLRC4, LRP8, TFPT, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, ASCC3, ZNF622, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, RNF20, CHURC1, EYA2, FBXL15, ARID3B, DEK, USF2, CD4, POLR3C, TNIP2, TAF7, MNDA, KRAS, TRIM32]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[CLIC5, OXTR, ABCC2, AMBP, IGFBP5, SPHK2, ITGA2, CAD, LNPEP, COMT, ADIPOR2, CRHR1, BYSL, NPPA, KRAS]
GO:0046326;positive regulation of glucose import;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.68372616907679;5.970411137910149;0.0028342881044734467;0.6803271032452366;[ADIPOR2]
GO:0046329;negative regulation of JNK cascade;12.0;0.9326813400603323;0.9144609826203107;9.607904965289386;1764.4523437695266;6.280566066213989;0.05905463204195212;0.7693087532925187;[ITCH, SFRP1, HDAC3, NCOR1, AMBP, PTPN22, PAFAH1B1, DACT1]
GO:1901857;positive regulation of cellular respiration;7.0;0.7671156992804218;0.7344772148974115;9.0689084645567;115.06907808635158;7.9853141584524145;0.0038512584881032984;0.7592887026755414;[CCNB1, PRELID1]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[MAML1, CCNH, GFI1, IKZF1, IKZF2, ELK1, TIAL1, SAP130, ZXDC, DPF2, SOX8, IER5, IER2, ZNF282, FLT3LG, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, IL23A, RFX4, BOLA3, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, ZNF25, MTDH, RAD21, HLTF, HIVEP1, HESX1, SCAP, HIVEP2, ZNF264, CREBBP, ZNF260, PBX3, ERLIN2, FLI1, SOX30, SETX, STAG1, PKIA, ZNF30, EZH2, AHCTF1, BTG2, CDKN1A, SETD3, ELL, OTUD7B, HOXC13, ZNF45, AATF, NIPBL, ZMYM2, C1QBP, HAVCR2, ZNF485, TSC22D4, NCOA6, TMEM173, PPRC1, ZFX, SIRT2, TOX4, GAL, NCOR1, MTF2, TFEC, MED20, ZNF350, NEDD8, TRAK1, ZNF69, RELA, ARNTL, RXRA, UBN1, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIB, NFIC, PSMC1, CAMK1, ZNF696, ARID4A, RORA, YY1, WWC3, EP300, ZNF564, GTF2I, TLE4, ZNF441, SSU72, PIAS2, ARMCX3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, BAG3, TPR, ZNF549, ZNF548, NLRP3, RIPK1, SUDS3, ZNF544, TFAP2A, DR1, UBE2I, NONO, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT1, SP1, SP3, MAFF, BCL3, ZNF658, NFE2L3, ZNF532, ZNF410, NFE2L1, CIITA, ONECUT2, DDX41, CHD1, FLCN, ZNF407, GATAD1, ZNF768, ZNF525, LRRFIP1, HIF1AN, DACT1, KLF12, TBP, KLF13, PEG3, BUD31, ZFP91, ARNT, SENP2, SAFB, ARID1A, CREB3, ZNF519, TFDP2, SETBP1, ELF4, LCOR, SMARCD2, HDAC3, HDAC1, WBP2, LRP8, ZNF622, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, FBXL15, ARID3B, DEK, USF2, TNIP2, TAF7]
GO:0006107;oxaloacetate metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.36615998802463;49.228254352165074;7.292166977892469;0.0016476253706144133;0.7238411236270654;[ACLY]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[BBS2, SPAG16, SPAST, UBE2B, FES, ZNF207, KIF20A, CLASP1, IQCG]
GO:0048873;homeostasis of number of cells within a tissue;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.75021374699733;6.444869117505266;8.953055804826206E-4;0.6527112189764278;[FLT3LG, VPS54, KRAS, CCR2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AVEN, BTG2, CDKN1A, DOCK8, KIF14, CIB1, AATF, UBE2Z, NUP62, CFL1, CASP2, CTSH, SOX8, PDGFRB, TSC22D4, FGA, DFFA, FCER1G, CSNK2A1, SPHK2, SPHK1, FGG, PLAUR, FLT3LG, YWHAZ, DDB1, CREB3, SFRP1, CFDP1, PTRH2, VDAC2, ADNP, EPHA1, PPID, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, MTDH, BAG3, CCL5, LMNA, NCKAP1L, RIPK1, CCL19, RFFL, SNCB, BID, NTSR1, TBX1, TFAP2A, PRELID1, UBE2B, EYA2, NONO, SYVN1, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, ITCH, IL6, SON, COPS5, TNIP2, BCL3, KRAS, PDCD1, TRIM32, MAD2L1, CPEB4]
GO:0006904;vesicle docking involved in exocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;32.65265176272962;6.039404009397101;0.0010928548690198408;0.6319757144917204;[RAB3B, VPS18, VPS33A, VPS33B, VPS11, RABEPK, RAB8B]
GO:0030433;ubiquitin-dependent ERAD pathway;10.0;0.9326813400603323;0.8815816818910864;9.600353375525426;603.0491029665483;5.557565922504363;0.02018351076733335;0.6994551915910392;[SEC13, RNF103, EDEM1, PSMC1, DERL3, SYVN1, UBQLN1, DERL2, MAN1B1, ERLIN2]
GO:0072715;cellular response to selenite ion;5.0;1.0;0.7902410118609202;9.628524252492122;56.33469972722095;9.777073627680469;0.0018854717019319196;0.7902410118609202;[EIF4A3]
GO:0032732;positive regulation of interleukin-1 production;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.64212018022187;6.063501560976162;0.0021969826883592772;0.6332080644001243;[NLRP12, NLRP7, CCL20, NLRP3, CCL19, HAVCR2]
